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ABSTRACT 
 
The objectives of this study were to 1) determine if high gait variability is 
associated with frailty; 2) test the inter-rater reliability of the Clinical Frailty Scale (CFS) 
and its concurrent validity against the Frailty Phenotype Index (FPI) in classifying frailty. 
Frailty status was determined by applying the FPI and CFS to the sample of 107 
community-dwelling older adults. Inter-rater reliability of the CFS was assessed using 
kappa statistics. Mantel-Haenszel test for trends evaluated concurrent validity of the CFS 
against the FPI components. Quantitative gait variables were assessed with an electronic 
walkway. Multivariable linear regression analysis evaluated the outcome of gait 
variability across CFS levels. The CFS showed substantial reliability and was correlated 
with FPI components. Increased frailty status was associated with higher variability in 
stride length, stride width, and stride time. This study demonstrates that high gait 
variability is associated with frailty, as defined by the CFS.  
KEYWORDS: gait, gait variability, frailty 
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CHAPTER 1- LITERATURE REVIEW 
1.1   The frailty syndrome  
The term, frail, has been widely used to describe the oldest old in the population, and 
was once considered to be synonymous with old age and disability (Lang et al., 2009). It 
has become increasingly recognized that, although, frailty is age-related, it is not caused 
by old age itself and is not a normal part of aging (Fried et al., 2005). The onset of frailty 
may be possibly preventable, avoided, or delayed (Morley, 2008). While the definition of 
“frailty” has evolved over the years, there remains a lack of consensus and is still a topic 
of controversy (Abellan van Kan et al., 2008). More recently, it has been proposed that 
frailty is a clinical syndrome, separate from disability and comorbidity with a distinct 
pathophysiological process (Fried, Ferrucci, Darer, Williamson, & Anderson, 2004). 
Under this framework frailty reflects subclinical physiological impairment in organ 
systems, physical function and cognitive capacity (Fried et al., 2001). Consequently, frail 
adults have a compromised homeostasis and an increased vulnerability to adverse events 
such as falls, institutionalization and death. 
1.1.1  Pathophysiology of frailty  
The mechanisms involved in the frailty process are unknown. It has been proposed 
that frailty is a complex syndrome which results in dysregulation of several systems 
across molecular, cellular and physiological levels (Halter & Hazzard, 2009). The “frailty 
cycle” has been proposed to describe the origin and progression of frailty (Fried et al., 
2001). Frailty, under this model, is associated with age-related biological and 
physiological alterations, however frailty is not universal to old age. The etiology of the 
frailty cycle is associated with low physical activity, inadequate nutrition, negative 
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environmental impact, injury, disease and genetics, which are compounded by the normal 
ageing process.  
At the molecular and cellular level, these factors produce reactive oxygen species, 
mitochondrial dysregulation, and damage to mitochondrial DNA (Halter & Hazzard, 
2009). Accumulation of these insults result in the alteration of biological mechanisms 
that regulate energy balance (Fried et al., 2005). Frailty is propagated as these altered 
energetics over time lead to changes in key physiological systems including the 
musculoskeletal, immune, hormonal, and inflammatory systems. A dysregulated immune 
response and activation of inflammatory pathways cause injury to muscle, decrease the 
rate of muscle repair, and trigger apoptosis (Hubbard, O'Mahony, Calver, & Woodhouse, 
2008; Hubbard, O'Mahony, Savva, Calver, & Woodhouse, 2009; Leng et al., 2004). 
Hormonal changes are associated with diminution of muscle mass, depressed appetite and 
food intake which affects body composition and nutriture (Mohr et al., 2007; Morley, 
Kim, & Haren, 2005). Compromised physiological function across these interconnected 
processes is central to the disruption of homeostatic mechanisms (Halter & Hazzard, 
2009).   
1.1.2 Clinical symptoms of frailty 
The clinical presentations as a result of altered biological and physiological 
systems are themselves interrelated and feedback into the progression of the frailty cycle 
(Figure 1.1) (Fried et al., 2001). An increased number of clinical symptoms reflect an 
increased severity in level of frailty. Sarcopenia, a central clinical manifestation of frailty, 
is characterised by the loss of lean body tissue, a decline in muscle fibre strength and an 
infiltration of adipose cells (Halter & Hazzard, 2009). This process ultimately leads to the 
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degeneration in function of remaining muscle, resulting in an additional decline in muscle 
strength and an increase in the perceived difficulty for a given exercise intensity (Janssen, 
Heymsfield, & Ross, 2002; Morley, 2008). This weakness in older adults may lead to 
avoidance of exercise and a reduced physical activity level which down regulates the 
resting metabolic rate, and total energy expenditure (Janssen et al., 2002). As a result, 
frail individuals present signs of decreased physical activity, fatigue, weakness, slowed 
performance, and in extreme cases, weight loss (Fried et al., 2001).  
 
Figure 1.1: Illustration of the self-perpetuating frailty cycle, resulting from 
dysregulated and impaired physiologic function.  
 
 
Copyright © The Journals of Gerontology from Fried, L. et al. (2001). 
 
 Over time, the combination of a sedentary state, energy dysregulation and 
homeostatic instability lead to under nutrition and further loss of lean body mass and 
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physical decline (Fried et al., 2005; Morley, 2001). Consequently, there is a self-
perpetuation of the frailty cycle. A pre-frail stage has been identified as a clinically silent 
stage in which, although there is a decline in performance and homeostatic mechanisms, 
physiological system are still able generate an adequate response to insults (Fried et al., 
2001; Lang et al., 2009).  However in frail individuals, these systems are unable to 
respond and adapt in the face of a stressor, propagating a frail individual into functional 
decline and increasing the risk of falls, disability, polymedication, increased risk of 
hospitalization, institutionalization and mortality (Figure 1.2) (Fried et al., 2001).  
 
Figure 1.2: The decline in performance and homeostatic mechanisms in the frailty 
process compared to normal aging.  
 
 
Adapted from Lang, P.O. et al. (2009). 
 
1.1.3 Assessment of frailty 
Currently, the most widely accepted model to identify frailty is the Frailty Phenotype 
Index (FPI) developed by Fried et al. (2001). The phenotype for frailty is based upon the 
physiological “frailty cycle” discussed previously. Frailty was defined as a clinical 
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syndrome in which the presence of the following criteria were explored: unintentional 
weight loss (≥10 lbs. in a year), self-reported exhaustion, weakness (grip strength in 
lowest 20% by gender and BMI), slow walking speed (slowest 20% by gender and 
height), and low physical activity (lowest 20% of kcals expended per week by gender). 
The presence of three or more of these criteria characterised the individual as “frail”, one 
or two items identified an individual as “pre-frail” or at an intermediate risk, and those 
with no frailty criteria were categorized as “not-frail”.  
In a large cohort of older adults the FPI was independently predictive, over three 
years, of several adverse clinical outcomes, including the incidence of falls, worsening 
mobility or ADL disability, hospitalization and death (Fried et al., 2001). The prevalence 
of frailty in the population increased with each five year age group and in each age group 
prevalence of frailty for women was twice as high then men. Also, those individuals 
categorized as “pre-frail”, showed an intermediate risk of developing poor clinical 
outcomes and an increased risk of developing frailty compared to those in the “not-frail” 
category. This study was able to provide a validated and predictive clinical definition of 
frailty in community dwelling older adults and support for the hypothesis of the “frailty 
cycle”. Furthermore, this study was able to provide evidence for the existence of an 
intermediate stage of risk between those not at risk, and those that are frail.   
1.2 The value of functional assessment in frail older adults 
Older adults are a heterogeneous population that present with atypical symptoms to 
common diseases, exhibit interacting effects of multiple comorbidities, and undergo age-
related physiological alterations that are separate from disease (Dharmarajan & Norman, 
2003). Assessment and health management of older adults represents a unique challenge 
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to clinicians. This is particularly evident in frail older adults. Based on recent estimates, 
almost 20% of people over age 75 are frail and could benefit from effective interventions 
to identify and minimize frailty (Hogan, MacKnight, & Bergman, 2003). To address the 
unique needs of frail individuals, the more thorough medical evaluation, termed 
„comprehensive geriatric assessment‟ (CGA), was developed to include the geriatric 
syndromes that affect the well-being of older adults. The domains of CGA include 
evaluation of physical heath, psychological health, social and economic support, 
environmental factors, and functional status (Solomon, 1988).   
Key features of frailty syndrome are weakness, lower limb dysfunction, and mobility 
impairment (Fried et al., 2001; Guralnik, Ferrucci, Simonsick, Salive, & Wallace, 1995; 
Walston & Fried, 1999) which may lead to functional decline (Janssen et al., 2002). 
Functional status can impact upon, and be impacted by, all the previously mentioned 
domains within the CGA (Figure 1.3) (Dharmarajan & Norman, 2003). Thus, to achieve 
optimum health status in frail older adults, improvement in function is a crucial objective 
of the CGA (Gill et al., 2004; Tinetti et al., 1999). Function is measured as the ability to 
perform routine tasks classified as activities of daily living (ADL) and instrumental 
activities of daily living (IADL) (Katz, 1983). ADL‟s include basic physical tasks such as 
bathing, dressing, toileting, transferring from a bed to a chair, continence, and feeding. 
IADL‟s represent behavioural and social activities such as using the telephone, using 
public transportation, grocery shopping, preparing meals, housework, taking medication, 
and managing financial responsibilities. Impairment in the ability to perform ADL‟s and 
IADL‟s is predictive of important health outcomes such as subsequent disability 
(Guralnik et al., 1995; 1989), risk of falls and fractures, and death (Visser, Deeg, Lips, 
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2003; Guralnik et al., 1994). These are all recognized causes of hospitalization and 
institutionalization and common adverse events associated with frailty. The capacity to 
remain independent reflects a high quality of life in older adults (Guralnik et al., 1989), 
making functional status an essential component of frailty assessment (Gill et al., 2004; 
Tinetti et al., 1999).   
 
Figure 1.3: Interacting domains of the comprehensive geriatric assessment. 
 
Adapted from Dharmarajan, T. S., & Norman, R. A. (2003). 
 
1.3  Gait and mobility 
Limitations in mobility, the ability to move one‟s body, interfere with functioning and 
are a major cause of loss of independence (Tinetti, Williams, & Mayewski, 1986). Gait is 
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considered to be one of the most important manifestations of mobility capacity 
(Hausdorff & Alexander, 2005). Gait, in humans, is the coordinated firing of muscles and 
limb movement to support the body and move it forward (Hausdorff, 2007). This cyclic 
pattern of lower limb movement requires input from the central nervous system, as well 
as sensory feedback to produce these highly coordinated movements for locomotion. In 
the mobility domain, gait and balance are fundamental markers of function in the lower 
extremities and the ability to carry out ADL‟s (Berg & Norman, 1996). 
1.3.1  The gait cycle 
The gait cycle is defined as the interval from when the heel of one foot makes 
initial contact with the ground to the next successive heel contact of the same foot 
(ipsilateral) (Figure 1.2) (Kirtley, 2006). The gait cycle is composed of two phases: the 
stance and swing phase. The stance phase is the interval between the reference foot 
making initial contact with the ground and ends when the foot is lifted off the ground. 
The stance phase makes up 60% of the normal adult gait cycle. The other 40% is 
represented by the swing phase which is the interval where the foot is off the ground and 
moving forward and ends just before the foot makes contact with the ground again.  
 
9 
Figure 1.4: Illustration of one stride in the gait cycle.   
 
 
 
 
 
 
 
 
 
Adapted from Montero-Odasso, M. (2003). 
 
The temporal parameters of the gait cycle include stride time which is the time it 
takes to complete one full stride measured in seconds (sec); single limb support time is 
the period of time during a stride when only one limb is in contact with the ground; 
double limb support time is the overlapping period when both limbs are in contact with 
the ground (Kirtley, 2006). The spatial parameters of the gait cycle include step length 
which is the linear distance between the heel of the trailing foot to the heel of the foot in 
front; stride length is the distance between the heel of one foot to the next successive heel 
contact of the same foot; step width is the distance from the midpoint of the footstep in 
front to the midline midpoint of the trailing footstep on the opposite foot (Figure 1.5). 
Gait velocity measures the speed of a walk on a level surface, quantified as distance 
covered per unit of time, and is most commonly expressed in meters per second (m/sec). 
Cadence refers to the rhythm of the walking pattern and is expressed as the number of 
steps taken in a given time (steps per minute). Cadence, stride length and speed are 
Double 
Support 
Double 
Support 
Right 
Single Support 
Left 
Single Support 
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related and change together. A subject with a longer stride length and increased cadence 
will have a shorter cycle time and subsequently a faster gait velocity. In a normal gait 
pattern, these measurements are symmetrical and equal for both legs.  
 
Figure 1.5: Spatial gait parameters of step length, stride length, and step width. 
 
 
 
 
1.3.2 Methods of gait analysis  
1.3.2.1   Observational analysis 
The simplest form of gait analysis can be completed with various methods that 
include paper-and pencil tests (Nelson, 1974; Sekiya, Nagasaki, Ito, & Furuna, 1997), 
stop watches, and video-based analysis (Perry & Burnfield, 2010). In a clinical setting 
these methods can provide a way to measure rudimentary gait parameters, such as gait 
velocity and cadence, in order to assess functional performance. However, this form of 
gait analysis is subject to human error in manual measurement of spatial and temporal 
parameters. These strategies are also labour intensive, time consuming and not efficient 
Step width Step width 
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for collecting valid and reliable gait data (McDonough et al., 2001; Bilney, Morris, & 
Webster, 2003; van Uden & Besser, 2004).  
1.3.2.2   3D Motion analysis 
Three-dimensional (3D) motion analysis is a highly sophisticated methodology and 
the most comprehensive gait analysis system as it allows measurement of both kinetic, 
kinematic gait parameters, and electromyography (EMG) data of the lower limbs (Perry 
& Burnfield, 2010). This analysis system utilizes optical, magnetic, or optoelectronic 
system to track movements of joint segments. A series of cameras, tracking markers 
placed over predetermined anatomical locations on the subject, and EMG measurement 
systems are used to determine spatio-temporal characteristics of gait and lower limb 
muscular activity. Although 3D motion analysis provides a thorough and comprehensive 
method of gait analysis, it is not a very practical tool in the clinical setting (Bilney et al., 
2003; McDonough, Batavia, Chen, Kwon, & Ziai, 2001; van Uden & Besser, 2004). The 
cost of equipment is expensive, requires a large space and laboratory setting to operate, 
and data collection is time-consuming and complex.   
1.3.2.3   Instrumented walkways 
A popular method of gait analysis is the use of computerized walkway systems, 
such as the GAITRite mat (Figure 1.6) (Bilney et al., 2003; McDonough et al., 2001; van 
Uden & Besser, 2004). The computerized mat is embedded with grids of pressure sensors 
to record an electronic imprint of each foot fall as a subject walks over the instrument. 
Data on gait parameters are calculated and displayed on a computer, connected to the mat 
and running software, as a subject completes a walk. These instruments have been proven 
to be highly valid and reliable tool for measuring a range of spatial and temporal 
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parameters of gait at usual and fast walking speeds in several populations. Advantages of 
the instrumented walkways over observational and video analysis is that it reduces the 
labour intensive and time-consuming aspect of measuring gait parameters and does not 
require extensive training (McDonough et al., 2001). These aspects make computerized 
instrumented walkways a very practical tool to use in a clinical or research setting and 
provide clinicians with quick results to objectively diagnose and monitor mobility 
impairments in patients.  
 
Figure 1.6: The computerised GAITRite walkway. 
 
 
Adapted from CIR Systems, Inc. at http://www.gaitrite.com/ Downloads/index-new.html. 
 
 
13 
1.3.3 Gait assessment in older adults 
Although gait disorders are not an inevitable part of aging, gait and balance 
impairment are common in older adults as a result of musculoskeletal, vascular, and 
neurological disease (Dharmarajan & Norman, 2003). Unlike young adults, gait disorders 
and mobility disability may be a result of multiple conditions and deficits across a 
number of physiological systems (Hausdorff & Alexander, 2005). Since multiple 
processes influence gait, impairment of gait in older adults can be considered a 
representation of the integrated effects of aging and comorbidities on health and 
functional status (Studenski et al., 2003). Early detection of gait impairment is effective 
in identifying those at a subclinical stage of disability (Guralnik et al., 1995), detecting 
underlying pathologies (Studenski et al., 2003), predictive of future falls (Montero-
Odasso et al., 2005; Tinetti, Speechley, & Ginter, 1988), and provides an opportunity to 
intervene to reduce functional decline (Cesari et al., 2009). A number of temporal and 
spatial parameters of the gait cycle can be objectively measured to evaluate gait and are 
associated with future adverse events (Whittle, 2007). 
1.4   Gait velocity 
Gait velocity is a comprehensive performance measure which captures multiple 
features of lower limb function (Bendall, Bassey, & Pearson, 1989; Tinetti et al., 1986). 
Maintaining a stable gait velocity requires the coordination of multiple integrated 
physiological systems working in a highly regulated manner (Alexander, 1996; 
Bohannon, 1997), including the nervous system, musculoskeletal system, as well as 
cardiopulmonary and sensory systems (Studenski et al., 2011). As these systems become 
altered with age, gait speed has been shown to diminish approximately 10-20% after the 
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age of 75 compared to younger adults (Alfaro-Acha, Al Snih, Raji, Markides, & 
Ottenbacher, 2007).   
1.4.1 Gait velocity a marker of adverse events  
An accelerated decline of gait speed can be an early warning sign for adverse 
health events and disabling diseases (Cesari et al., 2005; Montero-Odasso et al., 2005; 
Studenski et al., 2003). Studies across several large cohorts have established that older 
individuals categorized as slow walkers, walking slower than 1.0 m/s, have been shown 
to have a higher risk of future falls, hospitalization,  institutionalisation (Montero-Odasso 
et al., 2005), mobility disability (Cesari et al., 2005), cognitive decline (Inzitari et al., 
2007), and mortality (Studenski et al., 2011) compared to fast or intermediate walkers. It 
has been suggested that preclinical conditions, compounded by the effects of aging, affect 
the physiological domains involved in gait regulation (Studenski et al., 2011). This 
results in a high energy cost of walking and manifests in the loss of the capacity to 
maintain normal gait velocity (Bloem et al., 2000; Newman et al., 2001). Reduced gait 
velocity has been proposed as a “vital sign” which reflects physiological disturbances 
before they are completely clinically expressed (Studenski et al., 2011).  
Gait velocity is a test in which individuals walk along a course of a measured 
distance while being timed. The test is not time consuming and requires very little 
training to apply in the clinical setting. Furthermore, studies have shown that gait speed, 
as a single item, does just as well or better than complex performance batteries in 
predicting important health related outcomes in older adults (Guralnik et al., 2000; 
Studenski et al., 2003). As a result, gait velocity has become widely adopted as an 
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assessment tool to measure the onset or predictive risk of adverse outcomes in the process 
of aging (Abellan van Kan et al., 2009). 
1.5   Gait variability  
Examination of human gait patterns reveals complex fluctuations between and within 
strides even under steady environmental conditions (Figure 1.7) (Hausdorff, Peng, Ladin, 
Wei, & Goldberger, 1995; Beauchet et al., 2009). During a steady state walk, gait 
variability quantifies the amount of stride-to-stride fluctuation in temporal and spatial 
parameters of gait (Hausdorff, 2005; 2007). In the past, stride-to-stride fluctuations in 
gait measures were considered random noise and filtered out of analysis which was 
focused on average stride values (Newell & Corcos, 1993). Studies in gait dynamics have 
revealed that these fluctuations actually provide important insight beyond measures of the 
average stride into the regularity and control of limb-coordinated movements (Hausdorff, 
2007). In healthy conditions low stride to stride variability reflects a rhythmic and stable 
gait, whereas high gait variability reflects an unstable walking pattern (Beauchet et al., 
2009; Hausdorff et al., 1997; Hausdorff, Zemany, Peng, & Goldberger, 1999). The 
magnitude of stride-to-stride fluctuations is critical in understanding the physiology of 
gait (Lipsitz & Goldberger, 1992; Montero-Odasso et al., 2011), assessing age-related 
and pathological changes in the locomotor system (Gabell & Nayak, 1984; Hausdorff, 
Cudkowicz, Firtion, Wei, & Goldberger, 1998), and serves as a measure of function and 
mobility status in older adults (Callisaya et al., 2011; Hausdorff, Rios, & Edelberg, 
2001).  
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Figure 1.7: Stride-to-stride fluctuations in stride time (sec) about its means (solid 
line) in a healthy young adult. 
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1.5.1 Quantification and assessment of gait variability 
The variability in gait parameters can be quantified using the standard deviation 
(SD), a measure of dispersion from the mean value (Brach, Perera, Studenski, & 
Newman, 2008). However parameters with larger means tend to vary more and changes 
in the mean value of the parameter being analysed can heavily influence SD measures. 
SD is also dependent on the unit of measurement being taken (Brach et al., 2008; 
Hausdorff et al., 1998). To control for this, gait variability can also be quantified using 
the coefficient of variation (CoV) which is the ratio of the SD to the mean multiplied by 
100% (CoV = [(SD/Mean) × 100%]). The CoV is adjusted by the mean and therefore 
useful for comparing the degree of variation even if means are drastically different and 
have a range of values (Brach, Studenski, Perera, VanSwearingen, & Newman, 2008). 
Also, the CoV is a standardized measure which allows for the comparison of temporal 
and spatial variables in different units (Hausdorff, 2005). Montero-Odasso et al. (2009) 
showed that in a sample of older adults the test-retest reliability of CoV, measured by 
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intra class correlation (ICC), was “excellent” for several gait variables under both single 
task and dual task conditions (ICC=0.80-0.97).  
As previously mentioned, a validated method of quantitative gait analysis is the 
use of the computerized instrumented walkways, such as the GAITRite system (Bilney et 
al., 2003; McDonough et al., 2001; van Uden & Besser, 2004). The GAITRite mat 
provides a reliable and valid measure of gait in several populations, including older adults 
(Beauchet et al., 2011; Brach et al., 2008; Montero-Odasso et al., 2009). The GAITRite 
mat is able to accurately measure temporal and spatial gait parameters (van Uden & 
Besser, 2004) and can record several strides which is critical in the investigation of 
stride-to-stride changes (Hausdorff, 2005; Brach et al., 2008). Brach et al. (2008) showed 
that gait variability calculated from a limited number of steps (5-6 steps) had “poor” to 
“good” test-retest reliability (ICC=.22–.48), but reliability was improved when a greater 
number of steps (10–12 steps) were included (ICC=.40–.63). Too few steps can increase 
the error in estimating the mean, SD, and CoV values impose limitations in interpreting 
results of gait variability (Owings & Grabiner, 2003). Also, a fewer number of steps 
increases the sample size required to ensure sufficient statistical power to detect between-
group differences. A greater number of steps provide more data points which allows for a 
more sensitive assessment of change and more consistent measure of gait variability from 
stride-to-stride (Brach et al., 2008; Hausdorff, 2005) 
1.5.2 Gait variability and gait velocity 
Gait parameters illustrate overlapping features of the locomotor system, hence, 
various gait parameter measures are strongly related to each other (Kirtley, 2006). In 
order to evaluate the clinical utility of gait variability in the evaluation of mobility status 
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in older adults, understanding its relationship with gait speed is essential (Beauchet, 
Dubost, Herrmann, & Kressig, 2005; Beauchet et al., 2009; Dubost et al., 2006). 
Biomechanical analysis of gait mechanisms reveals a complex relationship between gait 
speed and gait variability. Some studies have failed to determine a relationship between 
the parameters (Frenkel-Toledo et al., 2005; Kang & Dingwell, 2008; Owings & 
Grabiner, 2004), while others have demonstrated a non-linear relationship (Beauchet et 
al., 2009; Jordan, Challis, & Newell, 2007; Van Emmerik, Wagenaar, Winogrodzka, & 
Wolters, 1999). 
A study of healthy older adult, as well as individuals with Parkinson‟s disease (PD) 
revealed that stride time variability increased at slow speeds (0.2-0.6m/s), compared to 
moderate walking speeds (0.8-1.4m/s) (Van Emmerik et al., 1999). Stride time variability 
has also been shown to increase at faster walking speeds during the walk-run transition of 
gait (2.0-2.2m/s) (Brisswalter & Mottet, 1996). Recently, Beauchet et al. (2009) 
demonstrated that as walking speed is decreased from a normal self-selected pace, stride 
time variability increased in a curvilinear manner in young adults (p<0.001) (Figure 1.8). 
It has been suggested that in this trend, low variability occurs at speeds which are 
mechanically optimal and require minimal energy consumption in order to maintain 
locomotion (Yamasaki et al., 1991; Danion, Varraine, Bonnard, & Pailhous, 2003). As a 
result of these findings, grouped differences in variability may be observed due to the 
confounding effects of gait speed (Van Emmerik et al., 1999; Beauchet et al., 2009).  
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Figure 1.8: Association between stride time variability (CoV %) and self-selected 
walking speed (cm/sec) in young healthy adults. Normal self-selected walking speed, 
used as the reference level, is denoted as 0 cm/sec.   
 
 
Copyright © BioMed Central from Beauchet, O. et al. (2009). 
 
However, several studies suggest that alterations in stride variability are a reflection 
of central nervous system impairment, and not simply a manifestation of slow walking 
speed (Hausdorff, 2004). Investigations of executive function on locomotor control of 
Alzheimer‟s disease (AD) patients demonstrated a significant association between 
increased stride variability during cognitively challenging tasks, while no difference was 
noted in gait speed (Sheridan, Solomont, Kowall, & Hausdorff, 2003). Maki et al. (1997) 
in a cohort of older adult fallers and non-fallers found that while gait speed was 
associated with a fear of falling it was not associated with fall risk among older adults. In 
comparison, stride variability was the single best predictor of fall risk but was not 
associated with fear of falling. Studies comparing gait parameters between healthy young 
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adults and healthy older adults have shown no significant difference in stride variability 
between the groups, even though older adults walked at reduced speeds (Gabell & Nayak, 
1984; Grabiner, Biswas, & Grabiner, 2001; Hausdorff, Edelberg, Mitchell, Goldberger, & 
Wei, 1997;).  
Taken together these studies demonstrate that gait variability measures may be more 
sensitive to subtle underlying pathologies, a good marker in discriminating between 
“vulnerable” and healthy populations, and a better predictor of falls than traditional 
measures such as gait speed (Gabell & Nayak, 1984; Grabiner et al., 2001; Hausdorff et 
al., 2001; Maki, 1997). While there is a relationship between variability measures and 
average speed values, slow gait speed is not a complete explanation of alterations in 
stride variability (Hausdorff, 2005; 2007). Measures of mean stride time, stride length 
and gait speed provide a good initial descriptor of a person's mobility and gait 
(Hausdorff, 2004). However, assessment of the alterations in gait variability provides 
important information beyond that of average velocity measures in understanding and 
predicting adverse events in older adults.  
1.5.3 Gait variability a marker of adverse events 
Walking is highly regulated and a finely tuned activity (Hausdorff, 2007). In healthy 
young and older adults the magnitude of stride-to-stride variability is relatively low 
during steady-state conditions, reflecting a rhythmic and more stable gait (Beauchet et al., 
2009; Hausdorff et al., 1997; 1999). It has been demonstrated that in the parameters of 
stride time and stride length, reflecting propulsion in the forward direction, a CoV value 
equal to or lower than 3% indicates normative variability (Danion et al., 2003; Hausdorff 
et al., 1997; 1999; Montero-Odasso et al., 2011). In the parameter of stride width and 
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double support time, which are associated with balance, although some degree of 
variability is considered adaptive, normative values in healthy older adults have yet to be 
determined (Brach, Berlin, VanSwearingen, Newman, & Studenski, 2005). The more 
variable gait is the more uncontrolled and unstable the walking pattern will be, resulting 
in unsteadiness and loss of balance (Hausdorff, 2005). Increased stride-to-stride 
variability has been linked to a high risk of falls (Hausdorff et al., 2001), cognitive 
decline, and neurological diseases such as AD (Sheridan et al., 2003), PD, and 
Huntington‟s disease (Hausdorff et al., 1998; 1997).  
Regulation of gait variability has been linked with multiple physiological systems 
including neural control, muscle function, postural control, as well as cardiovascular and 
cognitive domains (Hausdorff, 2005). It has been postulated that these systems 
monitoring gait stability may become altered in the face of physiological aging, overt 
disease, and subclinical conditions (Gabell & Nayak, 1984; Hausdorff et al., 1998; 
Montero-Odasso et al., 2011). Therefore, measures of gait variability have the potential to 
be utilized as a clinical tool for functional assessment of aging, disease severity, mobility 
status, response to therapeutic interventions, and a sensitive marker of risk to adverse 
health events in older adults (Hausdorff, 2005; 2007). 
1.5.3.1   Gait variability and fall risk 
Falls can have severe health consequences in the elderly due to the resulting 
injuries, mobility constraints, new disability, loss of independence, and fear of falling 
(Tinetti, 1987). In order to design targeted interventions for fall prevention, it is critical to 
determine risk factors for falls and identify sensitive markers for assessing fall risk 
(Guralnik, Ferrucci, Balfour, Volpato, & Di Iorio, 2001). Quantitative studies looking at 
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the relationship between fall risk and mobility demonstrate that gait variability measures 
can be used to prospectively identify older adults at a higher risk of falling (Verghese, 
Holtzer, Lipton, & Wong, 2009; Callisaya et al., 2011; Hausdorff et al., 2001; Maki, 
1997).  
Hausdorff et al. (2001) demonstrated that in a group of community-dwelling older 
adults, future fallers showed significantly increased variability in the parameters of stride 
time (p<0.04) than non-fallers at baseline (Figure 1.8). However, these two groups 
showed no significant difference at baseline in demographic characteristics, mental 
health, and ability to perform ADLs or IADLs. Fallers and non-fallers were also similar 
in measures of lower extremity function, gait speed, and balance, which are associated 
with fall risk, functional status, and vitality (Gill, Williams, & Tinetti, 1995; Guralnik et 
al., 1994; 2000; Studenski et al., 2011). Thus, even when other measures of fall risk only 
show subtle changes in function, gait variability measures may provide a more complete 
reflection of impairments in gait dynamics which increase instability. These findings 
highlight the value of utilizing gait variability measures in predicting fall risk in addition 
to other traditional assessment measures.  
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Figure 1.9: Illustration of fluctuations in stride time (sec), measured at baseline, in 
participant who experienced a fall during the 12 month follow-up period (SD= 
66ms), compared to a non-faller (SD=29ms). 
 
 
Copyright © American Academy of Physical Medicine and Rehabilitation from Hausdorff, J.M. et 
al. (2001). 
 
1.5.3.2   Gait variability and neurological  diseases 
Clinically, patients with neurological impairments, such as Huntington‟s disease, PD 
and AD show increased gait abnormalities in comparison to age-matched controls 
(Morris, 2000; Pettersson, Olsson, & Wahlund, 2005). Particularly, these patients have 
trouble maintaining balance and tend to fall more (Bloem, Grimbergen, Cramer, 
Willemsen, & Zwinderman, 2001; Schaafsma et al., 2003), leading to serious injuries, 
disability and effecting the quality of life in these populations (Morris, 2000; Pettersson 
et al., 2005). As seen in populations of elderly fallers, gait variability can be used as a 
relevant clinical measure of gait stability and degree of disease severity in those with 
pathological impairments (Nakamura, Meguro, & Sasaki, 1996).  
PD patients have rigid and unstable movement with characteristics symptoms of 
bradykinesia (slowness of gait), akinesia (cessation of movement) along with rest tremor 
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(Bond & Morris, 2000). Another feature of PD is the impaired ability to regulate gait 
rhythm, manifested as increased stride-to-stride variability (Baltadjieva, Giladi, 
Gruendlinger, Peretz, & Hausdorff, 2006; Blin, Ferrandez, & Serratrice, 1990; Hausdorff 
et al., 1998). Hausdorff et al. (1998) provided evidence that alteration in gait variability 
manifest relatively early in the disease process even though dramatic changes in speed 
may not yet be apparent. Additionally, stride time variability has been shown to be 
significantly increased in PD patient with a history of falls compared to those that did not 
fall, while parkinsonian features of bradykinesia, rigidity, and tremor showed no 
difference between these groups (Hausdorff et al., 2003; Schaafsma et al., 2003). 
Conferring the potential of gait variability measures, beyond the classic characteristics of 
PD, as useful indices of fall risk and disease progression in PD patients.  
AD patients early in the disease process have also been shown to perform poorly in 
motor performance assessments and have deteriorating physical ability compared to 
healthy individuals (Franssen, Souren, Torossian, & Reisberg, 1999; Nadkarni, Mawji, 
McIlroy, & Black, 2009; Pettersson et al., 2005; Wittwer, Andrews, Webster, & Menz, 
2008). Studies of mild to moderate AD patients, showed that stride length variability was 
significantly greater in the AD group compared to age-matched controls although both 
groups walked at similar speeds (Webster, Merory, & Wittwer, 2006; Wittwer, Webster, 
& Menz, 2010). Nakamura et al. (1996) demonstrated that while gait speed was not able 
to differentiate between AD fallers and non-fallers, stride length variability was 
significantly higher in AD fallers with mild and moderate disease severity (p<.01). 
Furthermore, changes in gait variability have been demonstrated to precede clinical 
manifestations of cognitive decline in initially non-demented older adults (Verghese, 
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Wang, Lipton, Holtzer, & Xue, 2007). Similar to PD patients, measures of gait variability 
may be an effective index in detecting motor impairments and gait instability in 
individuals with dementia who are at high risk for falls, even early in the disease process 
(Nakamura et al., 1996; Webster et al., 2006; Wittwer et al., 2010; Verghese et al., 2007).   
1.5.3.3    Gait variability and cognitive decline 
Walking is thought to be a “hard-wired” process regulated by subcortical areas of the 
basal ganglia and spinal regions in healthy young adults, and requires very little attention 
(Dubost et al., 2006; Woollacott & Shumway-Cook, 2002). However, investigations 
beyond the biomechanics of walking suggest that higher cortical regions of the prefrontal 
cortex, which is associated with executive function (EF), play an important role in the 
performance of learned motor tasks (Perry & Hodges, 1999). EF refers to a network of 
primary cognitive processes that use cortical and sensory information to produce “goal-
directed behaviours involving movement, action planning, working memory, and 
attention” (Sheridan et al., 2003). Studies of divided attention, an example of an EF, 
utilize the dual-task paradigm to give insight into the role of attention and EF on gait 
performance (Bond & Morris, 2000; Camicioli, Howieson, Lehman, & Kaye, 1997; 
Dubost et al., 2006; Sheridan et al., 2003; Springer et al., 2006).  
Walking while performing a secondary task, in the face of limited attentional 
resources, results in reduced performance in one or both tasks (Springer et al., 2006). 
Specifically, increased gait variability while dual tasking has been observed in the gait of 
older adults prone to falling due to limited cognitive resources (Bond & Morris, 2000; 
Dubost et al., 2006; Springer et al., 2006). Springer et al. (2006) showed that dual-tasking 
significantly increased stride-to-stride variability in fallers, whereas there was no change 
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in gait variability of non-fallers and young adults. All three groups had reduced gait 
velocity under dual-tasking conditions. Memory performance, a general marker of 
cognitive function, was not significantly different in fallers compared to non-fallers, 
although fallers did significantly worse on tests of EF. These findings demonstrate that 
increased gait variability in elderly fallers may be indicative of physiological deficits in 
cortical regions associated with EF which results in high gait variability and increased 
risk of falling. 
Patient populations at a high risk of falls, such as PD and AD patients, also show 
evidence that impairment of attention increases gait variability (Camicioli et al., 1997; 
Perry & Hodges, 1999; Sheridan et al., 2003; Yogev et al., 2005). It has been postulated 
that due to deficits in the basal ganglia in PD, gait stepping mechanisms recruit regions of 
the pre-frontal cortex during the execution of movement (Sheridan et al., 2003). Impaired 
gait stepping mechanisms increasingly rely on cortical pathways to generate a stable walk 
and put additional demands on attentional resources during multi-tasking (Bond & 
Morris, 2000). Furthermore, neuroimaging studies of AD show evidence that reduced 
cerebral blood flow in the pre-frontal lobe regions is associated with increased gait 
variability (Nakamura et al., 1997). Therefore, impaired cortical networks in the frontal 
lobe may play a role in reduced EF function and diminished regulation of gait variability.  
Recent studies of gait dynamics suggest that the regulation of gait, in healthy young 
and old adults, utilizes attention (Dubost et al., 2006; Springer et al., 2006). Aggravated 
gait instability, measured by increased gait variability, and diminished attention resources 
in PD, AD, and idiopathic fallers explains why these populations are vulnerable to 
environmental hazards (Woollacott & Shumway-Cook, 2002) and fall more often 
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(Hausdorff et al., 2003; Yogev et al., 2005). Increased gait variability in older adults 
indicates a lack of cognitive reserves and, thus, a reduced ability to compensate for gait 
impairments in challenging conditions (Yogev et al., 2005). This association also 
underscores the possibility of treating gait disturbances by targeting the cognitive regions 
through attention-enhancing medications or therapies to improve gait variability and 
reduce the risk of falls. 
1.5.4 Neural control of gait variability 
The underlying mechanisms which control stride-to-stride fluctuations of gait 
variability are unknown. However, in the last decade several studies have tried to 
elucidate which systems interact during gait dynamics (Beauchet et al., 2009; Rosano, 
Brach, Studenski, Longstreth, & Newman, 2007; Yogev-Seligmann, Hausdorff, & Giladi, 
2008; Zimmerman, Lipton, Pan, Hetherington, & Verghese, 2009). The association 
between neurological diseases and increased attentional demands with high gait 
variability suggests a neural control of gait variability beyond the musculoskeletal system 
(Hausdorff et al., 1998; Sheridan et al., 2003; Springer et al., 2006) . In healthy 
conditions, the locomotor system produces complex and coordinated movement of limbs 
and activation of the muscles by integrating signals from the motor cortex, cerebellum, 
basal ganglia, and sensory feedback from visual, vestibular and proprioceptive systems 
(Hausdorff et al., 2001). Temporal and spatial parameters of a stride are output measures 
and a result of these integrated networks of afferent and efferent components of the 
neuromuscular system (Hausdorff, 2007). It has been hypothesized that separate 
mechanisms are involved in generating and regulating different gait variables (Beauchet 
et al., 2009; 2011; Brisswalter & Mottet, 1996; Gabell & Nayak, 1984). Examining 
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fluctuations in separate stride parameters could therefore provide insight into the 
organization, regulation, dynamics, and function of the locomotor control system 
(Hausdorff, 2007).  
Gabel and Nayak (1984) proposed that step length and stride time are predominantly 
controlled by a gait-patterning mechanism, the spinal process which produces the 
repeated sequence of muscle contraction and relaxation during walking. The regulation of 
these parameters are predominantly controlled by locomotor centres in the basal ganglia 
and higher cortical regions of the frontal lobe as reflected in studies of increased gait 
variability in AD, PD, and Huntington‟s disease patient populations (Hausdorff et al., 
1998; 2003; 2007). High variability in stride time and stride length has thus been 
suggested to indicate impairment of the automatic stepping mechanism due to 
degeneration of higher cortical circuits involved in gait regulation (Gabell & Nayak, 
1984; Rosano et al., 2007). The parameters of step width and double support time are 
suggested to be involved in balance control mechanisms and reflect stability (Gabell & 
Nayak, 1984). Regulation of step width has been associated with muscle strength and the 
sensorimotor system rather than higher cognitive regions (Brach et al., 2005; Brach, 
Studenski et al., 2008; Callisaya, Blizzard, McGinley, Schmidt, & Srikanth, 2010). 
Increased double support time and step width variability could indicate compensation for 
instability due to impairments in balance control mechanisms (Gabell & Nayak, 1984).  
These findings demonstrate that variability in stride parameters provide insight into 
the multidimensional factors involved in locomotor control beyond the musculoskeletal 
system (Hausdorff et al., 2001). Below, Figure 1.10 represents the multiple physiological 
factors which are associated with gait instability. Impairments of these systems, which 
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can be observed with aging or disease, may be captured by increased variability across 
different gait parameters. Therefore, gait variability may serve as a marker of underlying 
deficits in the control mechanisms of gait that predisposes adverse health events.   
 
Figure 1.10: Physiological factors associated with gait instability. Illustration of the 
locomotor system and certain age-associated physiological changes (shaded boxes) which 
influence gait instability. CNS, central nervous system; PNS, peripheral nervous system; 
ROM, range of motion, CBF, cerebral blood flow. 
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1.5.5 Gait variability characterizes loss of physiological complexity  
In the healthy body, complexity refers to the intricate network of control systems, 
regulatory mechanisms, structures, and feedback loops which allow an organism to 
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survive, and carry out its function (Lipsitz & Goldberger, 1992). This intricacy of 
systems is evident in the assessment of heart rate and blood pressure regulation (Kaplan 
et al., 1991), respiratory dynamics (Peng et al., 2002), postural balance (Collins, De Luca, 
Burrows, & Lipsitz, 1995), and gait dynamics (Hausdorff et al., 1997). As a result, the 
healthy human body is resilient and able to maintain homeostasis, the ability to adapt and 
respond to stress (Lipsitz, 2002; 2004). It has been suggested by Lipsitz and Goldberger 
(1992) that the loss of complexity in anatomical structures and physiological systems is 
part of the normal aging process.  
With aging, there is a progressive degeneration of several tissues and organs (Lipsitz 
& Goldberger, 1992). Although, this loss of complexity threatens functional ability in 
older individuals, there are many redundancies and plasticity in human biological systems 
(Lipsitz, 2002). For example, the amount of muscle mass, neuronal circuits, and 
hormonal stores in the human body far exceed what is needed for usual physiological 
demands (Lang, Michel, & Zekry, 2009). This “physiological reserve” allows older 
adults to compensate for age-related physiological systems without negatively impacting 
their daily life routines (Lipsitz & Goldberger, 1992; Lipsitz, 2002; 2004).  
However, the continued loss of complexity disrupts the network of communication 
pathways between, and within, physiological systems (Lipsitz, 2002). Consequently, the 
inputs of physiological systems is disturbed and reduced and the resulting output signals 
become diminished and less complex. For instance, in older adults, reduction in 
complexity is seen in the breakdown of bone trabecular architecture, which characterizes 
osteoporosis; there is a diminished ability of the autonomic nervous system to regulate 
blood pressure, increasing the risk for hypertension (Lipsitz, Mietus, Moody, & 
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Goldberger, 1990); and decreased proprioception leads to increased postural sway 
increasing the risk of falls in older adults (Collins et al., 1995). This dysregulation in 
physiological systems, cause functional capacity of homeostasis to drop below a critical 
threshold, referred to as the “frailty threshold” (Figure 1.11) (Fried et al., 2005; Lipsitz, 
2002). At this point, the decline in functional ability is decreased to the extent that the 
older adult can no longer adapt and respond to internal or external stressors. This results 
in a marked increase in vulnerability to disability, disease and mortality (Fried et al., 
2005).  
As previously mentioned, the regulation of gait involves EF, and impairment of 
higher cortical regions is associated with increased gait variability (Springer et al., 2006; 
Woollacott & Shumway-Cook, 2002; Yogev-Seligmann et al., 2008). Additionally, the 
autonomic nervous system which is involved in the regulation of heart rate dynamics, an 
indicator of cardiovascular health, has been shown to be associated to gait instability 
(Hausdorff et al., 1994; Hausdorff, Herman, Baltadjieva, Gurevich, & Giladi, 2003). 
Increased gait variability has also been associated with low bone mineral density in 
women which was not detected by typical performance measures or gait speed 
(Palombaro et al., 2009). Furthermore, older adults demonstrate that diminished 
sensorimotor functions is associated with high gait variability in several parameters 
(Callisaya et al., 2010) and resistance training and improvement in muscle strength 
demonstrates reduced gait instability (Hausdorff et al., 2001). Under the framework of 
“physiological complexity” these findings demonstrate that gait variability is not only a 
measure of stability, but is also a sensitive marker of physiologic function. Hence, it has 
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been hypothesized that high gait variability characterizes the loss of complexity across 
several physiological parameters (Lipsitz, 2004; Montero-Odasso et al., 2011).   
 
Figure 1.11: Illustration of the loss of physiological complexity with ageing resulting 
in increased gait variability. Reduction in physiological inputs and connections leads to 
a decline in functional ability and loss of complexity in output signals, which may 
manifest as high gait variability. Frailty develops when functional level falls below the 
"frailty threshold,” and the individual can no longer adapt to stressors. 
 
 
 
 
 
 
 
 
 
 
Adapted from Lipsitz, L.A. (2002). 
 
1.6      Gait variability a marker of frailty 
As previously discussed, the inability to regulate gait performance and maintain 
rhythmicity, measured by gait variability, may indicate decreased complexity in several 
physiological systems (Hausdorff, 2005; 2007). Consequently, high gait variability has 
been established as an early marker of falls, mobility decline, and cognitive decline 
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which are also outcomes associated with frailty. Within the framework of a loss of 
complexity proposed by Lipsitz and Golberger (1992), it has been suggested that gait 
variability may be associated with frailty (Montero-Odasso et al., 2011). Several studies 
exploring the relationship between mobility and frailty have shown strong evidence that 
reduced gait velocity, specifically, is a marker of frailty (Abellan van Kan et al., 2008). 
However, beyond gait velocity, a limited number of studies have explored the 
relationship of gait variability and frailty. Recently, Montero-Odasso et al. (2011) 
investigated the association of frailty, as defined by the FPI, and gait variability in a 
cross-sectional study of 100 community-dwelling older adults (aged 75 years and older). 
Results of the study showed that high stride-to-stride variability was significantly 
associated with frailty status. 
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1.7    Rationale for study 
The previously mentioned study by Montero-Odasso et al. (2011) provides the first 
set of empirical evidence to further our understanding of mobility and frailty, in the 
parameter of gait variability. An important limitation of the cited study is that the 
included participants were categorized as frail using the FPI, a model that includes slow 
gait velocity as a criterion. Therefore, the high gait variability found in frail older 
participants may have been confounded by its association with slow gait and not with the 
participants‟ frailty status.  
In order to examine the true association between gait variability and frailty, a model 
that does not include gait velocity as a criterion is needed. If high gait variability is found 
in a sample of older adults with frailty, using a model which does not include gait as a 
criterion, this will demonstrate the independent association. In addition, this finding will 
provide support to the theory that frailty is a clinical syndrome with an underlying 
pathophysiology, characterised by the loss of dynamics in several systems (Fried et al., 
2001; Lipsitz, 2004). Examining the association of gait variability and frailty may 
provide further insight into the underlying mechanisms of this biological syndrome.  
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1.8   Purpose 
The purpose of the study was to determine the association between gait variability 
and frailty, as defined by the Clinical Frailty Scale (CFS), a model which does not 
specifically include gait velocity as a criterion. Furthermore, in order to apply the CFS in 
our sample, this study was designed to test the inter-reliability of the CFS and its 
concurrent validity against the Frailty Phenotype Index (FPI).  
1.9   Hypothesis 
We hypothesized that: 1) high gait variability would be associated with increased 
CFS frailty status; 2) the CFS would be reliable and valid against the FPI in its 
classification of frailty in our sample of community-dwelling older adults. 
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CHAPTER 2- METHODOLOGY 
 
2.1   Study design  
This study is a secondary analysis of data collected at the baseline assessment of the 
Frailty and Mobility Study (FMS). The FMS is a prospective cohort study evaluating the 
relationship between frailty, as defined by the Frailty Phenotype Index (FPI), and 
mobility in community-dwelling older adults. The current study sample is composed of 
the FMS participants recruited between the periods of October 2008 to December 2010.  
The Clinical Frailty Scale (CFS), an alternative frailty model to the FPI, was applied 
retrospectively to the dataset by two assessors to determine frailty of individual 
participants. Next, an analysis of gait data across the CFS frailty groups was performed to 
evaluate the association between gait variability, as a measure of gait impairment, and 
CFS frailty status in community-dwelling older adults. 
 
2.2  Study population 
Initially, a convenience sample of 109 older adults from the FMS cohort were 
screened for inclusion in our study; two subjects were excluded from this sample due to 
missing information of physical activity level and frailty scores bringing the final sample 
to 107 community-dwelling older adults. This sample was recruited from a naturally 
occurring retirement community (NORC) and comprise FMS cohort. The Cherryhill 
NORC is a 13-building apartment complex housing 2,500 older adults (mean age = 79.53 
± 9.53 years) in London, Ontario, Canada (Kloseck, Crilly, & Mannell, 2006). 
Participants were all community-dwelling older adults and eligible to participate in the 
study if they were aged 75 years or older, English speaking, and reported being able to 
 
37 
ambulate at least 10 meters independently without the use of a mobility aid. Exclusion 
criteria were the diagnosis of a terminal illness, life expectancy of less than 12 months, 
pending nursing home placement, hip or knee joint arthroplasty within the preceding six 
months, and a diagnosis of dementia.  
 
2.3  Outcome measures  
2.3.1  Frailty status  
2.3.1.1  Frailty Phenotype Index 
Currently, the most widely accepted model of frailty is the FPI (Appendix A) 
developed by Fried et al. (2001). The FPI was developed and operationalised in a cohort 
of 5201 older adults (65 years and older) from the Cardiovascular Health Study (CHS). In 
this sample, the FPI was found to be independently predictive of various adverse clinical 
outcomes, including the incidence of falls, worsening mobility or ADL disability, 
hospitalization and death. 
At baseline assessment of the FMS, frailty status in the participants was assessed 
using the five criteria of the FPI (Table 2.1): slow gait velocity, low physical activity, 
weakness, weight loss, and self-reported exhaustion. The slow gait velocity criterion was 
met if the participant, at usual pace, walked slower than one meter per second (m/sec). 
This cut-off was based on evidence from previous studies demonstrating that usual gait 
velocity below one (m/sec) is indicative of adverse health outcomes in older adults 
(Cesari et al., 2005; Montero-Odasso et al., 2004; 2005). The low physical activity 
criterion was assessed by asking the individual to describe their typical activity level as 
vigorously active, moderately active, or seldom active. A response of “seldom active”, 
defined as preferring sedentary activities, was used to operationalise low physical activity 
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level (Speechley et al., 2005). The weakness criterion was evaluated with a test of grip 
strength in the dominant hand using a hand held dynamometer (Jamar, Sammons Preston, 
Bolingbrook, IL). The weakness criterion was met when the average of three measures of 
grip strength was less than or equal to the cut-offs outlined in the FPI (Fried et al., 2001). 
The exhaustion criterion was evaluated using two questions from the Center for 
Epidemiologic Studies Depression Scale (Orme, Reis, & Herz, 1986): “Do you feel like 
everything you do takes an effort?” and “Have you ever felt like you could not get going 
in the previous 2 months?” An affirmative answer to one or both questions categorized 
participants as exhausted. In addition exhaustion was also evaluated with the question, 
“how much of the time during the past four weeks did you have a lot of energy?” An 
answer of a “little or none of the time” classified exhaustion in participants. The weight 
loss criterion was met if the participant reported losing more than 10 pounds 
unintentionally in the previous 12 months. A total frailty score was calculated based on 
the sum of the frailty components present. Individuals were then categorized into one of 
three frailty categories based on their frailty score as follows: frail, score of ≥3; pre-frail, 
score of 1–2; and not frail, score of 0. 
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Table 2.1: Measures of the individual Frailty Phenotype Index components in study 
participants.   
FPI components Measure of components 
Slow Gait Velocity  Gait velocity of ≤ 0.99 m/sec  
Low activity  Self-report of sedentary lifestyle 
Low frequency of physical activity (walking, chores, exercising, 
and leisure activities)  
Weakness  Lowest 20% in grip strength (adjusted by gender and BMI)  
Exhaustion/ Poor 
Endurance  
Positive answer from either of:  
(1) I felt that everything I did was an effort.  
(2) I could not get going.  
OR, answer of “A little/none of the time” to the question, “How 
much of the time during the past 4 weeks did you have a lot of 
energy?”  
Weight loss Self-report of >10lbs lost unintentionally in the last year  
 
2.3.1.2   Clinical Frailty Scale     
The FPI index includes gait velocity as a criterion which is known to be highly 
correlated with other quantitative gait parameters. In order to avoid a redundancy of the 
association between gait variability and gait velocity, frailty in our population was also 
categorized using the CFS (Appendix B), a validated frailty model which does not 
specifically itemize gait velocity as a criterion in identifying frailty.  
The CFS was developed from the Canadian Study of Health and Ageing (CSHA) 
by Rockwood et al. (2005) in order to provide clinicians with an easily applicable frailty 
assessment tool. In a sample of 2297 older participants from the CSHA, the CFS 
predicted mortality during a 5-year follow-up better than individual measures of 
cognition, functionality and comorbidity. The CFS is based on the clinical evaluation of a 
patient‟s status in the following clinical domains: mobility capabilities, level of energy, 
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physical activity and level of functionality. The scale uses clinical descriptors and figures 
to stratify older adults according to their level of vulnerability, ranging from CFS-1 (very 
fit), to CFS-9 (terminally ill). In order to apply the CFS to our sample, self-report 
measures from questionnaires (Appendix C) completed during baseline FMS assessment 
were compiled and reviewed for each study participant. Several demographic, clinical, 
and mobility measures from the FMS questionnaire were selected to represent the 
different clinical-functional domains included in the CFS.  
Two clinicians with expertise in frailty, a Geriatrician and Physiotherapist, 
independently evaluated each participant‟s demographic, clinical, and functional mobility 
information in order to apply the CFS and define frailty in our sample. Each participant 
was assigned a category of CFS-1(very fit) through CFS-7 (severely frail) on the CFS 
(Table 2.2). The categories of CFS-8 (very severely frail) and CFS-9 (terminally ill) 
represent adults who are totally dependent on others to carry out their activities of daily 
living (ADL) (Rockwood et al., 2005). Since our sample consists of older adults living 
independently in the community, the categories of CFS-8 and CFS-9 were not applicable. 
The clinicians were blind to the subjects‟ FPI frailty score and all quantitative gait 
parameters measures.  
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Table 2.2: Categories and descriptors of the Clinical Frailty Scale applied to study 
sample.  
1- Very fit  robust, active, energetic, motivated, fit 
2- Well  no active disease, less fit than people in category 1 
3- Managing Well  disease symptoms well controlled, not regularly active 
4-Vulnerable  symptoms limit activities, are “slowed up” 
5- Mildly frail 
 
 dependence for instrumental activities of daily living 
6- Moderately frail  need help with instrumental and non-instrumental 
activities of daily living 
7- Severely frail  completely dependent for personal care  
 
Information available to the clinicians to categorize individuals using the CFS is 
outlined below. Mobility capabilities were evaluated if a subject reported using a 
mobility aid (cane, walker, or other) to get around, history of falls in the last 6 months, 
comorbidities, and cognitive impairment. A fall was defined as “unintentionally coming 
to the ground or onto an object” ( Panel on Prevention of Falls in Older Persons, 
American Geriatrics Society, British Geriatrics Society, 2011; Cumming, Kelsey, & 
Nevitt, 1990; Lach et al., 1991). Self-report of physician diagnosed comorbidities was 
collected from a list of chronic medical conditions which included: diabetes, heart failure, 
hypertension, angina, myocardial function, cancer, previous strokes, osteoarthritis, and 
lung disease. Cognitive issues were ascertained from a self-report of memory issues, 
established using a 5-point Likert scale. Participants were asked to rate their memory in 
comparison to other people their age and to rate how their memory is now compared to 
five years ago (Speechley et al., 2005). Level of energy was assessed based on two 
questions. The first asked participants to describe their typical level of energy as low, 
moderate, or high. The second question asked “How often during the past four weeks did 
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you have a lot of energy?” for which the possible response options were: (a) all of the 
time, (b) half of the time, or (c) a little/none of the time (Orme et al., 1986).  
The level of physical activity criterion was assessed based on two questions. The 
first question asked subjects to describe their “typical activity level” as vigorously active, 
moderately active, or seldom active. The second question was a 5-point Likert scale 
asking participant to rate their activity level relative to other people their age (Speechley 
et al., 2005). Finally, functional capacity in basic ADL‟s was evaluated using a disability 
scale developed for community-dwelling older adults (Gill et al., 2004; Tinetti et al., 
1999). Participants rated their ability to perform the following ADL‟s: walking inside the 
house, bathing, upper-body dressing, lower body dressing, moving from a bed to a chair, 
toileting, feeding, and grooming. Scores for each activity were assigned based on the 
reported level of difficulty performing the task (no difficulty=0, some difficulty=1, or 
need assistance=2). The sum of the disability score ranges from 0 to 16, with higher 
scores representing a greater level of disability. Based on this information, each clinician 
assigned the participants a score on the CFS. Discrepancy in CFS scores between the two 
clinicians was resolved by consensus to obtain a single CFS score for each participant. In 
order to compare agreement of frailty status between the three levels of the FPI and six 
categories of the CFS, the CFS was collapsed to three levels to match the FPI 
classifications. CFS scores of one through three were categorized as “not frail”, category 
of CFS-4 was categorized as “pre-frail”, and CFS-5 and CFS-6 were categorized as 
“frail”. These cut-offs were created based on the clinical descriptors of the CFS.  
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2.3.2   Gait function 
Quantitative gait parameters were evaluated using the GAITRite system (CIR 
Systems Inc., Sparta, NJ). The computerized GAITRite mat (6 m × 0.5 m) is embedded 
with grids of pressure sensors to record an electronic imprint of each foot fall as a subject 
walks over the instrument. Data on gait parameters are calculated and displayed on a 
computer which is connected to the mat and running the GAITRite software, as a subject 
completes a walk. The GAITRite has been proven to be a highly valid and reliable tool 
for measuring a range of spatial and temporal parameters of gait at usual and fast walking 
speeds in a range of populations including older adults (Bilney et al., 2003; McDonough 
et al., 2001; van Uden & Besser, 2004). 
Participants were asked to walk across the GAITRite mat at a self-selected usual 
pace and at a fast pace. In order to limit the effects of acceleration and deceleration, start 
and stop points were marked on the floor one metre away from the edge of the mat. Three 
trials were performed at each pace, which allows for the collection of several strides in 
order to calculate a more reliable measure of stride-to-stride gait variability. Previous 
studies have shown poor test-retest reliability of gait variability when a limited number of 
strides are collected (Brach et al., 2008; Hausdorff, 2005). The following five quantitative 
gait variables were assessed: velocity (cm/s), stride time (ms), step width (cm), double 
support time (ms) and stride length (cm). These gait variables were chosen for their 
association with mobility decline, falls, and other adverse events in previously reported 
studies (Brach et al., 2005; Hausdorff et al., 2001; 2004; Montero-Odasso, 2011).  
Gait data of each step from all three walks was pooled to obtain a single mean and 
standard deviation (SD) value for each gait variability parameter evaluated. Gait velocity 
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at each pace was calculated as the average from all three trails. Variability in four gait 
parameters (stride time, stride length, double support time, and step width) was quantified 
using the coefficient of variation (CoV), which is the ratio of the SD to the mean 
multiplied by 100% (CoV = [(SD/Mean) × 100%]). The CoV is a standardized measure 
of variability which allows the comparison of gait variables measured in different units, 
with different means and having a range of values (Hausdorff, 2005). 
 
2.4   Statistical analysis 
Means and frequencies of socio-demographic and clinical characteristics were 
calculated to characterize the sample. Inter-rater reliability of applying the CFS to the 
study sample was estimated with a weighted kappa. To characterize the sample across 
CFS categories, means and frequencies of socio-demographic and clinical characteristics 
were calculated. Differences in descriptive characteristics of participants were evaluated 
using one-way analysis of variance (ANOVA) for continuous variables and Fisher‟s 
Exact test for categorical variables. Statistically significant findings from the one-way 
ANOVA were followed up by a post-hoc Tukey analysis to identify significant pair-wise 
associations. Frailty status in the same individual by CFS was compared to the number of 
FPI components (unintentional weight loss, weakness, exhaustion, slow gait velocity, and 
decreased physical activity) present using Spearman Rho correlation coefficients. The 
Mantel-Haenszel test was used to analyse for trend in proportions of each FPI component 
across CFS categories. Agreement between the FPI and the collapsed 3-level CFS was 
assessed using weighted kappa statistic. Gait variability parameters (stride time, stride 
length, stride width, double support time) stratified across the CFS groups, were 
evaluated using one-way ANOVA for usual and fast pace conditions. This analysis was 
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then followed with a planned test for trends in means and post-hoc Tukey analysis. 
Multivariable linear regression analysis was utilized to assess the relationship of 
categorical CFS levels to each of the gait variability parameters under usual and fast pace 
conditions with the CFS-1 group as the reference category. The dependent variable was 
gait variability and the exposure variable of interest was frailty level as identified by the 
CFS. The regression analyses were adjusted for age and history of falls to control for the 
effects of confounding. These variables were selected based on evidence from previously 
established studies that suggest increased age and a history of falls are associated with 
higher gait variability (Callisaya et al., 2010; Grabiner et al., 2001; Kang & Dingwell, 
2008). As a secondary analysis, regression analysis was repeated treating the CFS as a 
continuous variable to assess the association of gait parameters with increasing CFS 
frailty status. Statistical analysis for the Kappa coefficient was performed using the 
software MedCalc (version 12.2, MedCalc Software, Mariakerke, Belgium). All other 
statistical analyses were performed using PASW (version 18.0, SPSS Inc., Chicago IL). 
The level of significance for all tests was set at p< 0.05. 
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CHAPTER 3- RESULTS 
 
3.1   Study population and demographics 
A total of 107 community-dwelling older adults, aged 75 years and above were 
included in our initial sample. Three subjects were excluded from further analysis of gait 
function because clinicians were unable to reach consensus on assigning a CFS frailty 
score to these participants, yielding a final sample of 104 older adults. The average age of 
our participants was [Mean (SD)] 82.1 (5.4) years old, 79% of whom were women with 
an average Body Mass Index (BMI) [Mean (SD)] of 26.4 (4.5). Twenty-nine percent of 
participants reported having a history of falls in the previous six months, 42% reported 
having memory problems, and 48% of participants reported being in „good‟ health. 
Characteristics and self-report health measures of the study sample are presented in Table 
3.1.  
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Notes: n, group size; SD, standard deviation; BMI, body mass 
index; FPI, Frailty Phenotype Index 
Table 3.1: Demographic characteristics of study participants in total sample. 
 
.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
3.2   CFS inter-rater reliability 
 The inter-rater reliability between clinicians in assessing frailty by applying the 
CFS in individual participants is outlined in Table 3.2. In the initial independent rating of 
CFS scores, the clinicians agreed on the exact scoring in 50% (n=54) of cases and 
disagreed in 50% (n=53) of cases. Of the disagreements, 77% (n=41) were by one 
category, 21% (n=11) were by two categories, and 2% (n=1) were by three categories on 
the CFS. The direction of disagreements outlined in Table 3.2 indicates Clinician 2 
consistently rated participants higher on the CFS scale than Clinician 1. Calculation of 
Variable Full Sample 
(n=107)  
Age,  mean (SD) 82.1 (5.4) 
Women, n (%) 85 (79%) 
Body Mass Index, mean (SD) 26.4 (4.5) 
Comorbidities, mean (SD) 3.1 (2.2) 
Use of Mobility Aid, n (%) 40 (37%) 
Number of Medications, mean (SD) 4.2 (3.2) 
Disability Score, mean (SD) 2.2 (2.8) 
History of Falls in last 6 months, n (%) 32 (29%) 
Self-report of memory problems, n (%) 45 (42%) 
Self-report of Health Status, n (%) 
Excellent 
Very Good  
Good 
Fair 
Poor 
 
8 (7%) 
35 (33%) 
51 (48%) 
14 (13%) 
1 (1%) 
FPI, n (%) 
      Not Frail 
      Pre-Frail 
      Frail 
 
13 (12%) 
60 (56%) 
34 (32%) 
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the weighted kappa coefficient, the measure of agreement reached beyond chance, was 
Kw=0.76, 95% CI (0.68, 0.85), a value that represents „substantial agreement‟ (Sim & 
Wright, 2005) between raters.   
 
Table 3.2: Assessment of CFS frailty status in study participants by two clinicians. 
 
               Clinician 1      
      
1 
Very Fit 
2 
Well 
3 
Managing 
Well 
4  
Vulnerable 
5 
Mildly 
Frail 
6 
Moderately 
Frail  Total 
   
1 Very Fit  
 
--- 5 1 --- --- --- 6 
   
2 Well  
 
--- 14 1 1 1 --- 17 
Clinician 
2 
3 Managing 
Well  
--- 4 15 2 3 --- 24 
   
4 Vulnerable  
 
--- 2 9 12 7 --- 30 
   
5 Mildly Frail 
  
--- --- 2 5 5 1 13 
   
6 Moderately 
Frail  
--- --- --- 2 7 8 17 
 Total   0 25 28 22 23 9 107 
 
Note: shaded area represents cases of exact agreement between clinicians in CFS frailty 
classification. 
 
3.3   CFS validity 
After reviewing the cases in which there was a disagreement in CFS scores, 
consensus was reached between clinicians on a single CFS score for each participant. The 
sample ranged from CFS-1through CFS-6 with a majority of subjects categorized as 
CFS-3 (n=28). Demographic and clinical characteristics of study participants as a whole 
and also stratified by CFS frailty status are presented in Table 3.3. No statistically 
significant differences in age, gender or BMI were noted across the CFS groups. 
However, participants with a high CFS score showed higher use of mobility aids, 
increased number of comorbidities, more polypharmacy, poorer functional status, higher 
history of falls, and greater report of memory problems. Those who were scored as CFS-6 
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showed a significantly increased disability in ADL‟s [Mean (SD)] 7.8 (3.1) compared to 
all other CFS groups. This group also had the highest prevalence for use of mobility aids 
(83%) and self-report of memory problems (67%). The CFS- 5 group showed a 
significantly higher number of comorbidities compared to the categories of CFS-1, CFS-
2, and CFS-3, and higher number of prescribed medications compared to CFS-2. In the 
complete sample, 30% of subjects reported a fall within the last 6 months, with the 
greatest prevalence of falls occurring in the CFS-4 (47%) and CFS-5 groups (45%).  
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Table 3.3: Characteristics of study participants stratified by Clinical Frailty Scale status. 
 
 
Variable 
 
Total 
Sample 
(n=104) 
1 2 3 4 5 6   
Very Fit 
(n=4) 
Well 
(n=19) 
Managing 
Well 
(n=28) 
Vulnerable 
(n=19) 
Mildly 
Frail 
(n=22) 
Moderately Frail 
(n=12) 
p-value* 
Age,  mean (SD) 82.1 (5.4) 79.5 (4.7) 81.6 (5.6) 81.6 (6.2) 82.6 (5.4) 83.5 (4.7) 81.3 (4.4) .643 
Women, n (%) 83 (80%) 3 (75%) 18 (95%) 20 (71%) 13 (68%) 19 (86%) 10 (83%) .249 
Body Mass Index, 
mean (SD) 
26.4 (4.6) 27.0 (2.7) 26.1 (4.8) 26.6 (4.5) 25.3 (3.7) 25.3 (3.4) 29.9 (6.6)  
.085 
Use of Mobility Aid, 
n (%) 
39 (38%) 0 (0%) 0 (0%) 4 (14%) 9 (47%) 16 (73%) 10 (83%) <.001 
Comorbidities, mean 
(SD) 
3.1 (2.2) 1.0 (0.8)a 2.1 (1.7)a 2.6 (2.2)a 3.4 (1.6) 4.6 (2.7)b 3.5 (1.6) .001 
Number of 
Medications, mean 
(SD) 
4.1 (3.2) 1.5 (0.6) 2.5 (2.0)a 4.8 (3.7) 3.5 (2.1) 5.9 (3.4)b 4.0 (3.6) .005 
Disability Score, 
mean (SD) 
2.1 (2.8) 0 (0%)a 0.8 (1.9)a 1.0 (1.4)a 1.7 (2.0)a 2.5 (1.5)a 7.8 (3.1)b <.001 
History of Falls in 
last 6 months, n (%) 
31 (30%) 1 (25%) 0 (0%) 7 (25%) 9 (47%) 10 (45%) 4 (33%) .004 
Self-report of 
memory problems, n 
(%) 
44 (42%) 1 (25%) 5 (26%) 14 (50%) 7 (37%) 9 (41%) 8 (67%) .292 
 
Notes: n, group size; SD, standard deviation; BMI, body mass index; *, One-way ANOVA (Analysis of Variance) or Fisher’s Exact test 
analysis, statistical significance set at p<0.05; a, b, denote statistically significant between group differences at p<0.05, values with the same 
letter not significantly different from one another, different letter indicates statistical significance between values. 
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Participants with higher CFS frailty status also had an increased number of FPI 
components present (Table 3.4). There was a significant correlation between increasing 
CFS frailty status and an increased number of FPI components present (rs= 0.685, 
p<0.001). Analysis using the Mantel-Haenszel test for trend revealed a significant 
positive linear trend between increasing CFS frailty status and an increased prevalence of 
slow gait velocity, low physical activity, low hand grip, unintentional weight loss, and 
exhaustion (Table 3.5).  
 
Table 3.4: Proportion of the individual Frailty Phenotype Index components present 
among the stud sample stratified by Clinical Frailty Scale status. 
 
Notes: n, group size; *, Fisher’s Exact test analysis; statistical significance set at p<0.05. 
 
Table 3.5: Results of Mantel-Haenszel test for trend of proportion of Frailty 
Phenotype Index components present with increasing Clinical Frailty Scale status. 
 
 
 
 
 
 
 
 
 
FPI 
Components, 
n (%) 
 
Total 
Sample 
(n=104) 
1 2 3 4 5 6  
Very Fit 
(n=4) 
Well 
(n=19) 
Managing 
Well 
(n=28) 
Vulnerable 
(n=19) 
Mildly 
Frail 
(n=22) 
Moderately 
Frail 
(n=12) 
*p-
value 
Slow Gait 
Velocity 
55 (53%) 1 (25%) 4 (21%) 8 (29%) 12 (63%) 19 (86%) 11 (92%) <.001 
Low Physical 
Activity 
12 (12%) 0 (0%) 1 (5%) 2 (7%) 0 (0%) 3 (18%) 6 (42%) .003 
Low Hand 
Grip 
69 (66%) 0 (0%) 10 (53%) 20 (71%) 14 (74%) 16 (73%) 9 (75%) .068 
Unintentional 
Weight Loss 
7 (7%) 0 (0%) 0 (0%) 0 (0%) 1 (5%) 3 (14%) 3 (25%) .032 
Exhaustion 53 (51%) 0 (0%) 3 (16%) 10 (36%) 13 (68%) 18 (82%) 9 (75%) <.001 
FPI Components X
2
MH p-value 
Slow Gait Velocity 30.09 <.001 
Low Physical Activity 10.46 .001 
Low Hand Grip 5.14 .023 
Unintentional Weight Loss 9.806 .002 
Exhaustion 26.10 <.001 
Notes: degrees of freedom=1, statistical significance set at p<0.05. 
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Agreement between the collapsed CFS and FPI in categorizing participants as 
“not frail”, “pre-frail”, or “frail” showed an agreement in 44% (n=46) of cases, and 
disagreement in 56% (n=58) of cases. Agreement between the scales in classifying frailty 
yielded a weighted kappa coefficient of Kw=0.51, 95% CI (0.40, 0.63), which represents 
a “moderate association” (Table 3.6) (Sim & Wright, 2005). 
 
Table 3.6: Agreement in frailty classification between the collapsed Frailty 
Phenotype Index and Clinical Frailty Scale in study sample. 
 
FPI 
CFS 
 Not Frail Pre-Frail Frail Total 
Not Frail 13 -- -- 13 
Pre-Frail 35 11 12 58 
Frail 3 8 22 33 
Total 51 19 34 104 
 
Note: shaded area represents cases of exact agreement between CFS and FPI in frailty 
classification. 
 
3.4   Gait Variability 
Quantitative gait characteristics, stratified by CFS frailty status, are presented in 
Table 3.7. The parameters of average gait velocity, stride time, stride length, double 
support time and step width showed significant difference across CFS frailty groups 
under both usual and fast pace condition (p<.001). At usual pace, there was a significant 
difference in mean gait variability values of stride time, stride length, and step width 
among CFS frailty groups. Post-hoc Tukey analysis showed no significant associations in 
stride time and stride length variability. However, CFS-5 was significantly different from 
CFS-1and CFS-2 in step width variability. 
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The ANOVA analysis at fast pace revealed significant differences among CFS 
frailty groups in gait variability parameters of stride length and step width. In the stride 
length variability parameter, CFS-5 was significantly different from CFS-2 and CFS-4. In 
the step width variability parameter, groups CFS-1 through CFS-4, although not different 
from each other, were significantly different from group CFS-5. Gait variability 
parameters of stride time and double support time were not found to be significant across 
frailty groups at fast pace. Overall, stride length and step width variability showed a 
greater difference across CFS frailty groups under fast pace walking condition than usual 
walking pace conditions.  
Analysis of trends in the gait parameter data showed a significant linear trend in 
certain parameters with increasing CFS frailty status. At usual pace, stride length and 
stride width showed a significant positive linear trend; at fast pace, stride time, stride 
length, and stride width showed a significant positive linear trend with increasing frailty 
level. Results of trend analyses are displayed in Table 3.8.     
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Table 3.7a: Gait characteristics stratified by Clinical Frailty Scale status at usual pace. 
 
1 
Very Fit 
2 
Well 
3 
Managing Well 
4 
Vulnerable 
5 
Mildly Frail 
6 
Moderately 
Frail 
p-value  
Mean quantitative gait characteristics at usual walking pace, [Mean±SD]:  
Gait Velocity, 
cm/sec 
122.08±22.79
a 
115.83±18.4a
 
104.57±14.60
a 
100.14±20.95
a 
77.91±20.16
b 
71.77±20.05
b 
<.001 
Stride time, 
msec 
1096.20±96.39
 
1052.51±93.23
a 
1094.85±72.59
a 
1144.86±118.81 1206.77±116.94
b
 1220.62±174.97
b
 <.001 
Stride length, 
cm 
132.85±17.85
a
 121.59±16.51
a
 114.40±11.80
 a
 113.32±17.30
 a
 93.24 ±20.83
 b
 86.27±18.59
 b
 <.001 
Double 
support time, 
sec 
0.33±0.04
 ab
 0.31±0.45
a
 0.33±0.06
 a
 0.35 ±0.07
 a
 0.44 ±0.10
 bc
 0.47±0.12
 cd
 <.001 
Step width, cm 67.26±8.59
 a
 61.59±7.97
 a
 58.43±5.26
a
 58.23±8.12
a
 49.05±9.70
 b
 45.92±7.76
 b
 <.001 
Mean gait variability (CoV%) values at usual walking pace, [CoV±SD]: 
Stride time 2.69±0.70 3.67±1.88 3.58±1.34 4.49 ±2.40 5.14±2.52 4.46 ±1.63 .041 
Stride length 2.23±0.49 4.10±1.26 5.47±3.06 5.09±2.61 6.14±2.63 5.56 ±2.20 .028 
Double 
support time 
11.96±10.04 8.85±3.76 9.32±3.43 8.67±2.42 10.01 ±4.92 8.42 ±1.47 .569 
Step width 3.47±0.88
a
 5.15±1.18
a
 6.27±2.15 6.36±2.45 7.71 ±3.23
b
 6.41 ±1.81 .003 
 
Notes: SD, standard deviation; one-way ANOVA (Analysis of Variance), statistical significance set at p<0.05; CoV, coefficient of variation, 
calculated by the formula: [SD/ mean] x100%; a, b, denote statistically significant between group differences at p<0.05, values with the same letter 
not significantly different from one another, different letter indicates statistical significance between values.     
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Table 3.7.b: Gait characteristics stratified by Clinical Frailty Scale status at fast pace.   
 
1 
Very Fit 
2 
Well 
3 
Managing Well 
4 
Vulnerable 
5 
Mildly Frail 
6 
Moderately Frail 
p-
value  
Mean quantitative gait characteristics at fast walking pace, [Mean ± SD]:  
Gait Velocity, 
cm/sec 
150.85±31.17 a 149.88±23.65 a 137.24±18.40 a 131.18±20.96 a 105.80±26.19 b 92.57±18.91 b <.001 
Stride time, 
msec 
965.38±78.45 899.42±84.86 a 953.57±74.37 972.42±103.14 1025.22±127.38b 1052.44±124.84 b <.001 
Stride length, 
cm 
144.78±20.09 a 134.55±17.89 a 130.45±12.38 a 127.19±18.71 a 107.77±22.61 b 97.20±16.95 b <.001 
Double support 
time, sec 
0.25±0.04 ab 0.23±0.04 a 0.26±0.05 a 0.27 ±0.05 a 0.32 ±0.08 bc 0.36±0.08 cd <.001 
Step width, cm 72.84±9.64 a 67.90±8.71 a 66.11±6.07 a 64.92±9.01 a 55.20±10.90 b 48.07±12.71 b <.001 
Mean gait variability (CoV%) values at fast walking pace [CoV±SD]: 
Stride time 2.39±0.37 2.95±0.94 2.88±1.22 3.23±1.06 3.26±1.24 4.20±2.30 .062 
Stride length 2.46±0.66 3.23±0.74a 3.97±1.95 3.40±1.45a 4.97±2.11b 4.98 ±1.81 .002 
Double support 
time 
7.15±1.43 8.41±3.12 9.15±5.43 10.58±7.79 8.31±3.04 9.91 ±4.32 .627 
Step width 3.68±0.09a 4.60±1.06a 4.83±2.04a 4.92±1.55a 7.21±2.91b 6.52±1.56 <.001 
 
Notes: SD, standard deviation; one-way ANOVA (Analysis of Variance), statistical significance set at p<0.05; CoV, coefficient of variation, 
calculated by the formula: [SD/ mean] x100%. a, b, denote statistically significant between group differences at p<0.05, values with the same letter 
not significantly different from one another, different letter indicates statistical significance between values.     
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Table 3.8: Results of trend analysis of gait variability parameters with increasing 
CFS status. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results of the linear regression analysis for the relationship of the CFS frailty 
status to the gait variability parameters, the dependent variable, are presented in Table 3.9 
and Table 3.10. Increased frailty status was significantly associated with several 
quantitative measures of gait variability at usual and fast pace. In the unadjusted analysis, 
at usual pace, increased stride time variability was associated with CFS-5; increased 
stride length variability was significantly associated with frailty categories of CFS-3 
through CFS-6; increased step width variability was significantly associated with frailty 
categories of CFS- 3 through CFS-5. At fast pace, stride length variability was 
significantly associated with frailty categories of CFS-5 and CFS-6. Under fast pace 
condition step width variability was significantly associated with frailty categories of 
CFS-5 and CFS-6. Stride time variability, under fast pace conditions, was associated with 
the CFS-6 group.  Double support time variability was not associated with frailty status 
under usual or fast pace conditions.  
Variable F p-value 
Usual gait variability (CoV%) parameters 
Stride time 5.56 .020 
Stride length 8.78 .004 
Double support time 1.53 .219 
Stride Width 10.30 .002 
Fast gait variability (CoV%) parameters 
Stride time 6.73 .011 
Stride length 11.19 .001 
Double support time 0.95 .332 
Stride Width 13.56 <.001 
Notes: degrees of freedom= 1, statistical significance set at p<0.05 
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In the adjusted regression analysis, at usual pace, stride length variability 
remained significantly associated with CFS-3, CFS-5 and CFS-6. Similarly, step width 
variability was associated with CFS-3, CFS-5 and CFS-6. Double support time and stride 
time variability was not associated with frailty status in usual pace conditions. At fast 
pace, stride time variability was associated with frailty category of CFS-6. Stride length 
variability was significantly associated with CFS-5 and CFS-6 groups. Step with 
variability was also associated with CFS-5 and CFS-6. Double support time variability 
was not associated with CFS frailty categories in the fast pace condition.  
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Table 3.9: Unadjusted multivariable linear regression comparing association of Clinical Frailty Scale status on outcome of gait 
variability parameters under usual and fast pace conditions. 
 
Notes: The dependent variable: measure of gait variability; independent variable: CFS frailty; 1 very-fit group is the reference category; CI, 
confidence interval. Bold values are statistically significant at p<.05. 
 
 Regression Coefficients, (95% CI) 
2-Well 3-Managing Well 4-Vulnerable 5-Mildly Frail 6-Moderately Frail 
Gait variability (CoV%) values at usual walking pace:  
Stride Time 0.98 (-1.17, 3.13) 
p=.369 
0.89 (-1.20, 2.98) 
p=.401 
1.80 (-0.35, 3.95) p=.099 2.45 (0.32, 4.57) p=.024 1.77 (-0.49, 4.02) 
p=.123 
Stride Length 1.87 (-.84, 4.58) 
p=.173 
3.24 (0.61, 5.87) p=.016 2.86 (0.15, 5.57) p=.039 3.91 (1.23, 6.58) p=.005 3.33 (0.49, 6.17) 
p=.022 
Step Width 1.67 (-0.83, 4.18) 
p=.188 
2.79 (0.36, 5.23) p=.025 2.88 (0.38, 5.39) p=.025 4.23 (1.76, 6.71) p=.001 -3.53 (-8.03, 0.97)  
p=.123 
Double 
Support Time 
-3.10 (-7.39, 1.19) 
p=.154 
-2.63 (-6.80, 1.54) 
p=.213 
-3.29 (-7.58, 1.00) p=.131 -1.94 (-6.18, 2.30) 
p=.366 
 2.93 (0.31, 5.56)  
p=.029 
Gait variability (CoV%) values at fast walking pace: 
Stride Time 0.57 (-0.86, 1.99) 
p=.433 
0.50 (-0.89, 1.89) 
p=.476 
0.85 (-.58, 2.28) p=.240 0.87 (-0.54, 2.28) 
p=.223 
1.82 (0.32, 3.31) 
p=.018 
Stride Length 0.77 (-1.08, 2.62) 
p=.410 
1.51 (-0.28, 3.31) 
p=.098 
0.94 (-0.91, 2.78) p=.315 2.51 (0.68, 4.33) 
p=.008 
2.52 (0.58, 4.46) 
p=.011 
Step Width .93 (-1.23, 3.08) 
p=.395 
1.15 (-.94, 3.24) 
p=.277 
1.24 (-0.91, 3.40) p=.254 3.53 (1.41, 5.66) 
p=.001 
2.84 (0.59, 5.10) 
p=.014 
Double 
Support Time 
1.27 (-4.21, 6.75) 
p=.647 
2.01 (-3.32, 7.33) 
p=.456 
3.44 (-2.04, 8.92) p=.216 1.16 (-4.25, 6.57) 
p=.672 
2.77 (-2.98, 8.52) 
p=.342 
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Table 3.10: Adjusted multivariable linear regression comparing association of Clinical Frailty Scale status on the outcome of 
gait variability parameters under usual and fast pace conditions. 
 
 
Notes: The dependent variable: measure of gait variability; independent variable: CFS frailty; 1 very-fit group is the reference category; regression 
models are adjusted for age and history of falls in the previous 6 months; CI, confidence interval. Bold values are statistically significant at p<.05 
  Regression Coefficients, (95% CI) 
2 Well 3 Managing Well 4 Vulnerable 5 Mildly Frail 6 Moderately Frail 
Gait variability (CoV%) values at usual walking pace:  
Stride Time 0.92 (-1.16, 3.00) p= 
.877 
0.65 (-1.36, 2.66) p= .524 1.27 (-0.82, 3.37) 
p=.231 
1.83 (-0.254, 3.91) p=.085 1.50 (-0.67, 3.68) 
p=.173 
Stride Length 1.77 (-0.876, 4.42) 
p=.187 
2.96 (0.40, 5.53) p=.024 2.28 (-0.39, 4.95) 
p=.093 
3.23 (0.58, 5.88) p=.018 3.04 (0.27, 5.81) 
p=.032 
Step Width 1.77 (-0.69, 4.22) 
p=.156 
2.59 (0.21, 4.96) p=.033 2.31 (-0.17, 4.78) 
p=.068 
3.59 (1.13, 6.04) p=.005 2.66 (0.95, 5.23) 
p=.042 
Double 
Support Time 
-3.25 (-7.54, 1.05) 
p=.137 
-2.90 (-7.07, 1.26) p=.169 -3.83 (-8.16, 0.51) 
p=.083 
-2.59 (-6.89, 1.71) p=.235 -3.81 (-8.30,0.69) 
p=.096 
Gait variability (CoV%) values at fast walking pace: 
Stride Time 0.48 (-0.95, 1.91) 
p=.505 
0.41 (-0.97, 1.80) 
p=.554 
0.71 (-0.73, 2.16) 
p=.328 
0.70 (-0.73, 2.13) 
p=.336 
1.74 (0.24, 3.24) 
p=.023 
Stride Length 0.77 (-1.06, 2.59) 
p=.408 
1.36 (-0.40, 3.13) 
p=.131 
0.58 (-1.26, 2.42) 
p=.533 
2.09 (0.27, 3.92) p=.025 2.34 (0.43, 4.25) 
p=.017 
Step Width 0.91 (-1.26, 3.08) 
p=.407 
1.06 (-1.05, 3.16) 
p=.321 
1.02 (-1.16, 3.21) 
p=.355 
3.28 (1.11, 5.45) p=.003 2.73 (0.46, 5.00) 
p=.019 
Double 
Support Time 
1.22 (-4.35, 6.78) 
p=.665 
1.92 (-3.47, 7.31) 
p=.481 
3.27 (-2.34, 8.89) 
p=.250 
0.96 (-4.61, 6.53) 
p=.733 
2.68 (-0.16, 0.24) 
p=.676 
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3.5  Secondary analysis 
 
Linear regression analysis gait variability parameters and gait speed across CFS 
frailty status repeated with CFS as a continuous variable are presented in Figures 3.1-3.5. 
The trend line representing the linear regression equation indicates the direction of change 
in gait parameters with increasing CFS frailty status. The gait variability parameters of 
stride time, stride length and step width showed a positive linear association with 
increasing CFS frailty status. Gait velocity showed a negative linear association with 
increasing CFS frailty status. Double support time showed a negative association at usual 
pace conditions, and a positive linear association at fast pace conditions with increasing 
CFS status.  
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Figure 3.1:  Linear regression for the association of CFS status on the outcome of stride time 
variability (CoV %) in study sample under a) usual pace and b) fast pace conditions.    
 
Figure 3.1.a)  
 
 
 
Figure 3.1.b)  
 
 Note: R2, coefficient of determination, represents amount of variation in stride time 
variability (CoV%) due to CFS frailty status.  
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Figure 3.2: Linear regression for the association of CFS status on the outcome of stride 
length variability (CoV %) in study sample under a) usual pace and b) fast pace conditions.    
 
 3.2. a)  
 
 
3.2. b)  
 
 
 
 
Note: R2, coefficient of determination, represents amount of variation in stride length 
variability (CoV%) due to CFS frailty status.  
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Figure 3.3: Linear regression for the association of CFS status on the outcome of double 
support time variability (CoV %) in study sample under a) usual pace and b) fast pace 
conditions. 
 
Figure 3.3.a)  
 
Figure 3.3.b)  
 
Note: R2, coefficient of determination, represents amount of variation in double support 
time variability (CoV%) due to CFS frailty status.  
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Figure 3.4:  Linear regression for the association of CFS status on the outcome of step width 
variability (CoV %) in study sample under a) usual pace and b) fast pace conditions.  
 
Figure 3.4.a)   
 
 
Figure 3.4.b)  
 
 
 
 
 
Note: R2, coefficient of determination, represents amount of variation in step width 
variability (CoV%) due to CFS frailty status.  
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Figure 3.5:  Linear regression for the association of CFS status on the outcome of gait 
velocity (cm/sec) in study sample under a) usual pace and b) fast pace condition.  
 
Figure 3.5.a)  
 
 
Figure 3.6.b)  
 
Note: R2, coefficient of determination, represents amount of variation in gait velocity 
(cm/sec) due to CFS frailty status.  
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CHAPTER 4- DISCUSSION 
 
This study has demonstrated that low performance in quantitative gait parameters, in 
addition to gait velocity, are associated with frailty. Specifically, high gait variability is 
associated with frailty, as defined by the CFS, a model which does not include gait 
velocity as a criterion in assessing frailty. Specifically, high variability in the parameters 
of stride length, stride width were associated with frailty at both usual and fast pace; 
stride time was associated with frailty under the fast pace condition. These results suggest 
that regulation of gait is impaired in older adults with frailty. Since gait variability is 
understood to be an expression of gait dynamics, our results provide additional evidence 
that frailty is a syndrome characterized with loss of dynamic in the regulation of gait.  
Additionally, the results demonstrate the CFS achieved substantial inter-rater reliability 
and moderate agreement with the established FPI in assessing frailty in our sample.   
 
4.1   CFS inter-rater reliability  
The substantial degree of agreement between clinicians in assessing frailty established 
the reliability of the CFS scale in our sample of community-dwelling older adults. 
Consistent with this study‟s results, Rockwood et al. (2005) found that the application of 
the CFS to a large cohort of elderly adults demonstrated high inter-rater reliability. In 
contrast to the previous study, this study included blinded evaluation from two assessors 
of each participant‟s CFS status. The current study design may provide a more accurate 
measure of inter-rater reliability for the application of the CFS in a sample of community-
dwelling older adults.    
Disagreement between clinicians in participant CFS scores was resolved through a 
consensus discussion. This process highlighted important disparities in how each clinician 
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applied and interpreted the CFS. Clinician 2 consistently scored participants higher on the 
CFS than Clinician 1, suggesting a bias effect between the clinicians in CFS ratings. This 
bias may account for several of the disagreements by just one CFS category and 
ultimately resulting in a more conservative kappa value. Discussion between the 
clinicians also highlighted that this bias was partially due to disagreement on what items 
in the construct of frailty, as defined by the CFS, should be given importance or 
considered first. A high rate of disagreement was attributed to how much importance the 
clinicians gave to the figures included along with the verbal descriptors of the CFS 
categories. For instance, the figure accompanying category CFS-4 illustrates an individual 
using a cane, whereas the CFS-5 category illustrates an individual using a walker. 
Clinicians disagreed on whether an individual who uses a walker should be considered to 
be frailer than someone who uses a cane as prescription and use of one type of aid over 
another is influenced by personal choice and not just physical need alone. This difference 
in how clinicians used the figures resulted in a greater number of disagreements in rating 
participants as either CFS-4 or CFS-5 than other categories. Another point of discussion, 
and source of disagreement, surrounded the specific inclusion of „disability in bathing‟ as 
a descriptor of category CFS-6. Clinicians disagreed on whether disability in bathing 
alone should be a deciding factor in categorizing an individual as CFS-6 or if other 
functional measures should be taken into consideration in rating this CFS category. In two 
cases, this difference in judgement accounted for a disagreement by two CFS categories 
(CFS-4 and CFS-6).  
Overall, these disagreements highlight the reliability of the CFS could be further 
improved by first reaching consensus between clinicians on a standard procedure to apply 
the scale in a practical setting. As reflected in the discussion above, disagreements in 
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clinical opinion can lead to a critical difference in classifying someone as frail or not frail. 
A uniform approach between clinicians in assessing the items included in the CFS 
construct of frailty would minimize differences and any bias in rating patients‟ frailty 
status on the CFS.  
4.2   Validity of the CFS 
The CFS is a tool that may be readily administered in the clinical setting based on its 
simplicity for retrieving information from clinical history and physical exams (Rockwood 
et al., 2005). The CFS provides an advantage from alternative frailty models that require 
more complex measures and are not easy to use in the clinical setting. Although the 
established FPI has been demonstrated to be a valid assessment tool of frailty, it requires 
several tests which may be time consuming, and measures of hand grip strength and gait 
velocity which may not be readily administered in the clinical setting. To our knowledge, 
this study is the first of its kind to validate the CFS against the FPI in the same sample.  
The CFS demonstrated good construct validity with factors associated with increased 
vulnerability and frailty in older adults. For instance, our findings showed that high frailty 
status, represented by CFS-5 and CFS-6, was associated with a higher number of 
medications, a high prevalence of falls, and self-report of cognitive impairment. The 
pathophysiology of frailty which leads to inflammation, abnormal immune function, and 
loss of homeostatic capacity is integral to the progression of several chronic diseases  
(Hubbard et al., 2008; Hubbard et al., 2009., Lipsitz, 2002) including diabetes, cancer, 
hypertension, and cardiovascular disease (Roschelle, 2011). The treatment of these 
diseases in frail individuals is consequently also associated with polypharmacy (Farrell, 
Szeto, & Shamji, 2011). Furthermore, previous studies have shown that frailty status is 
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strongly associated with cognitive impairment (Boyle, Buchman, Wilson, Leurgans, & 
Bennett, 2010; Buchman, Boyle, Wilson, Tang, & Bennett, 2007) and frail individuals 
with cognitive impairment are significantly more likely to develop disability in activities 
of daily living (ADL) and instrumental activities daily living (IADL) (Avila-Funes et al., 
2009). A previous investigation showed frailty status measured by the CFS and the FPI, 
were both strongly associated with cognitive decline in frail adults (Mitnitski, Fallah, 
Rockwood, & Rockwood, 2011). The associations of poor clinical status with an 
increased CFS frailty status in our sample suggests that the underlying construct of the 
CFS is able to capture frailty as a state that leaves older adults vulnerable to adverse 
health outcome.  
Furthermore, increasing CFS frailty status showed a positive linear association with 
the number of FPI components present. The CFS-6 group showed the highest prevalence 
of all five FPI components (slow gait velocity, low physical activity, low hand grip, and 
unintentional weight loss). The FPI components are a measure of function and regulation 
in multiple physiological systems and detect the presence of deficits in homeostasis which 
may leave an older individual vulnerable to internal or external stressors (Fried et al., 
2001). The presence of a linear association between the CFS and FPI components suggest 
that the CFS shows a similar sensitivity to changes in underlying physiological function 
which are associated with frailty. Our results support Mitnitski et al. (2011) suggestion of 
frailty as a valid state that can be measured with different models. In light of the debate 
on how to define and asses frailty (Abellan van Kan et al., 2008), our findings display 
evidence that the CFS is comparable to the established FPI in quantifying reduced 
physiological reserve in older adults, with the advantage of being easy to administer in 
the clinical setting.   
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Assessment of concurrent validity of the collapsed CFS scale showed “moderate” 
agreement to the FPI in classifying frailty in the study sample. Some of the disagreement 
between the two scales may have been due to the fact that in order to compare the six 
categories of the CFS to the collapsed three levels of the FPI, the CFS categories also had 
to be grouped into three categories of “not frail”, “pre-frail”, and “frail”. The multiple 
levels of the CFS scale, and the increasing number of FPI components present capture the 
progression of physical decline in an individual as frailty develops. Pooling data from 
these different categories by creating seemingly arbitrary cut-offs discards important 
information. For instance, individuals that present two FPI components are evidently in 
an increased state of vulnerability than those with only one component present. However, 
in order to make a diagnosis, the FPI pools individuals with either one or two components 
present into the “pre-frail” category losing any important distinctions between these 
groups. Although frailty has been theoretically described as a continuous variable 
(Lipsitz, 2002), cut-offs are created in order to make a clinical diagnosis, and this may 
add to measurement error.  
 The greatest disagreement in comparison of the CFS and FPI was seen in 35 cases 
which were defined as “not frail” by the CFS and “pre-frail” by the FPI. The categories of 
CFS-1 through CFS-3 were pooled into one “not frail” group in order to draw 
comparisons to the FPI “not frail” group. Examination of the CFS-3 group showed that 
although these participants are considered to be “managing well” most participants had at 
least one FPI component present. This suggests that the CFS may not be as sensitive as 
the FPI in capturing those that are in a pre-frail stage. The inclusion of CFS-3 in the “not 
frail” group mixed pre-frail participants into this category and consequently, our 
 
71 
assessment of agreement in frailty classification between the scales may have been more 
conservative.  
4.3   Gait variability                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
Our results demonstrate that the regulation of gait is impaired in older adults with 
frailty as indicated by high gait variability in gait performance. In the unadjusted 
multivariable linear regression analysis, at usual pace, a significant association was found 
between the spatial parameters of stride length variability and step width variability with 
frailty. This association remained significant after adjusting for potential confounders. 
Gabell and Nayak (1984) suggest that step width variability is related to balance control 
in older adults. Increased step width variability in older adults has been shown to be 
associated with poorer performance of postural control and reduced proprioceptive visual 
input (Callisaya et al., 2010) rather than higher cognitive control (Brach, Berlin et al., 
2005; Brach, Studenski et al., 2008; Rosano et al., 2007). Increased step width variability 
in our sample of frail adults may therefore reflect a disruption of balance mechanisms and 
increased instability while walking (Callisaya et al., 2010; Gabell & Nayak, 1984; 
Beauchet, Annweiler et al., 2009). Therefore, increased step width variability may serve 
as a sensitive marker of age or disease related decline in sensory feedback and reduced 
ability of the vestibular systems ability to maintain postural control (Callisaya et al., 
2010). Disruption of balance control, manifested as increased step width variability has 
been linked to a high history of falls in community-dwelling older adults (Brach, Berlin et 
al., 2005). Although step width variability as a prospective marker of falls has not been 
studied, it can be postulated that a disruption of balance control systems may increase the 
risk of future falls, an outcome also related to frailty (Abellan van Kan et al., 2008; Fried 
et al., 2001; Fried et al., 2004; Lipsitz, 2004).  
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Previous investigations have suggested that stride length is controlled by the gait-
patterning mechanism which produces the repeated sequence of muscle contraction and 
relaxation during walking (Gabell & Nayak, 1984). Regulation of this mechanism has 
been attributed to higher cortical and subcortical regions of the brain (Dubost et al., 
2006). Increased stride length variability has been associated with basal ganglia infracts 
and white matter abnormalities in community dwelling older adults (Rosano et al., 2007) 
and patients with Parkinson‟s disease (PD) (Blin et al., 1990) and Alzheimer‟s disease 
(AD) (Nakamura et al., 1996; Webster et al., 2006). Consequently, a high degree of 
variability in stride length may indicate a failure of the automatic stepping mechanism 
due to impairments in cortical circuits involved in gait regulation (Gabell & Nayak, 1984; 
Rosano et al., 2007). The association of increased stride length variability in our sample 
of frail older adults could therefore be a marker of subclinical cognitive impairment. This 
is supported by studies which have demonstrated that physical frailty is associated with 
incidence of mild cognitive impairment in community-dwelling older adults (Boyle et al., 
2010; Buchman et al., 2007). Increased stride length variability has also been 
demonstrated to predict risk of future falls in older adults (Maki, 1997), an outcome also 
related to frailty and increased vulnerability (Abellan van Kan et al., 2008). Under usual 
pace conditions, stride length and stride width variability also showed increased 
variability with the category of CFS-3. This may have been due to the fact that although 
the CFS classifies this group as “managing well”, this category appeared to include 
individuals who were actually pre-frail according to the FPI. The inclusion of pre-frail 
individuals in this group may have consequently significantly increased the average gait 
variability values observed in this group.  
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Double support time variability, thought to be controlled by balance mechanisms, did 
not show any significant difference among the frailty groups at either pace of walking. In 
patient populations with neurological  diseases such as Huntington‟s disease, PD 
(Hausdorff et al., 1997; 1998) and AD (Wittwer et al., 2008), significantly increased 
double support time variability was observed compared to young healthy controls. In 
comparison, community-dwelling older adults showed a subtle increase but no significant 
difference in double support time variability in comparison to young adults (Gabell & 
Nayak, 1984). Taking these previous findings and our results into considerations, it may 
be suggested that increased double support time variability is related to the pathology of 
central nervous system disorders (Brach et al., 2005; Rosano et al., 2007) and may only 
be seen in advanced stages of frailty. Due to the nature of our sample, our participants 
were relatively healthy and therefore showed no increase in double support time 
variability.    
Stride time, thought to be influenced by the gait-patterning mechanism, showed no 
significant difference with frailty status under usual pace. However, stride time was 
significantly increased in the CFS-6 category under fast pace conditions. Fast walking is a 
more demanding task and requires additional physical effort than walking at a self-
selected pace (Ko, Hausdorff, & Ferrucci, 2010). Fast pace walking may allow for 
differences in functionality and fitness to emerge that identify older adults with lower 
physiological reserve and physical frailty (Brisswalter & Mottet, 1996; Fitzpatrick et al., 
2007). Stride time variability may not have been sufficiently stressed under usual pace 
conditions in frail adults. The increased demands imposed on gait patterning mechanisms 
by fast walking may have allowed for exposure of sub-clinical impairments in stride time 
variability regulation.  
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Frailty ensues when there is an aggregate loss of complexity and dysregulation across 
multiple physiological networks resulting in the loss of homeostatic capacity (Lipsitz, 
2004). This loss of complexity in physiological systems can be captured by measuring the 
variability of physiological output signals (Collins et al., 1995; Kaplan et al., 1991; 
Montero-Odasso et al., 2011; Peng et al., 2002). Within this framework, measures of gait 
performance can be seen as a reflection of the functional capacity of systems involved in 
maintaining a steady gait pattern (Montero-Odasso et al., 2011). As previously 
mentioned, regulation of gait variability parameters involves several components of the 
musculoskeletal system, sensorimotor system, and higher cognitive regions. The presence 
of high gait variability in our sample of older adults with frailty may signify reduced 
complexity across these physiological systems (Lipsitz & Goldberger, 1992; Lipsitz, 
2002; 2004). Our findings of impaired gait performance due to high gait variability 
support the hypothesis that an aggregate loss of complexity with aging in physiological 
systems underlies the development frailty. It can be suggested that high gait variability is 
not only a marker of falls, mobility decline, and cognitive deterioration, but may also be a 
marker of frailty which leaves older adults vulnerable to the previously mentioned 
adverse outcomes (Montero-Odasso et al., 2011). 
Previous investigations have shown strong evidence that gait velocity is a marker of 
frailty (Abellan van Kan et al., 2008). Results from our study support these previous 
findings and indicate that decreased gait velocity is associated with increased CFS frailty 
status. In comparison to gait variability, gait velocity was more strongly associated with 
increased CFS frailty status. Although gait velocity is a robust screening tool for frailty, 
the added value of gait variability as a marker of frailty may lie in detecting frailty in 
those individuals who walk above the normal gait speed cut-offs and. As it has been 
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demonstrated in previous studies, gait variability is a predictor of falls even in 
individual‟s who walk above 1 m/s (Hausdorff et al., 2001; Verghese et al., 2009).  
4.4   Limitations 
The findings of the current study need to be interpreted with some caution in light of 
certain limitations. Firstly, the study is limited by the cross-sectional design. Even though 
an association between gait variability and frailty status was found, the temporal order of 
this association cannot be determined. In order to further test this association, prospective 
studies of frailty status and changes in gait variability need to be conducted. An important 
factor to consider when performance measures are repeated, particularly over a short time 
frame, is the possibility of a learning effect. However, in this study the gait tasks 
performed by participants were not novel activities that would be expected to have 
changed or improved with repetition over the three trials. Additionally, the GAITRite mat 
does not impede or obstruct the participants‟ performance during a gait task so improved 
comfort with the testing equipment should not be a consideration. Therefore, any learning 
as a result of performing three trials is expected to have had a negligible impact on 
measures of gait velocity and gait variability. Furthermore, if there was a learning effect, 
resulting in improved gait performance and reduced gait variability, this would have 
biased our results towards the null. As we found a statistically significant association, our 
findings are a conservative estimate of the change in gait variability expected with 
increased frailty status. Another potential limitation was the lack of data on fear of falling 
which can confound values of gait variability. However, gait measures were adjusted for 
a history of falls which correlates strongly with fear of falling (Friedman, Munoz, West, 
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Rubin, & Fried, 2002) and the presence of residual confounding by fear of falling is 
expected to be very small.  
This study is also limited by the retrospective application of the CFS. CFS ratings 
were done by clinicians using data from self-report measures and questionnaires. 
Assessment of frailty status without the participant present could have resulted in the loss 
of vital information that can be ascertained by clinicians from the physical examination 
and interaction with the individual (Gupta, 2008). This could have resulted in an 
inaccurate judgement of the patients‟ frailty status leading to an under or overestimation 
of CFS frailty classification by the clinicians. Furthermore, descriptors included in the 
CFS for certain categories were limited and there was a lack of instructions in how to 
apply the CFS. As a result, certain individuals did not seem to fit into one distinct 
category making frailty classification difficult and led to critical disagreement in frailty 
rating between clinicians. Also, we were limited by the lack of information on 
participants‟ ability to perform IADL‟s, which the CFS specifies as a specific descriptor 
in categorizing an individual as CFS-5. Another limitation is the use of a convenience 
sample of relatively healthy community-dwelling older adults from the Cherryhill 
community. Most people were categorized as CFS-3, hence our sample represents older 
adults with relatively good health and functionality. Therefore, our findings are probably 
a conservative estimate of the magnitude of association between gait variability and 
frailty and can be only generalized to community-dwelling older adults who are able to 
live independently. Also, the overall narrow range of frailty statuses and small 
distribution in some categories could account for the lack of association in the CFS-6 with 
certain gait variability measures due to insufficient power to detect an association. 
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Therefore, reproduction of our findings in a larger sample of older adults with a range of 
frailty statuses is warranted. 
4.5   Future directions 
 
 This study has established the association between gait variability and frailty, and 
a prospective study is needed to determine the temporal order of the relationship of gait 
variability and frailty. This can help determine the clinical utility of gait variability as a 
predictor of frailty and subsequent adverse event in older adults. Future studies need to be 
done in order to determine if increased gait variability is a marker for frailty in those who 
walk at a normal speed and otherwise show no signs of impaired gait. This would be 
important in determining the value of gait variability as a measure of frailty in addition to 
gait velocity. The relation of gait variability and frailty status suggests that gait variability 
may also be used as a potential measure to detect the magnitude of change in older adults 
undergoing therapies and interventions to improve frailty status. Stride-to-stride 
fluctuations are critical in understanding the physiology of gait and, therefore, gait 
variability may serve as a clinical tool in assessing reduced function in physiological 
systems involved in gait performance, and a predictor frailty status in older adults.  
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CHAPTER 5- CONCLUSION 
 
 This study demonstrated that several gait variability parameters are associated 
with frailty. Frailty, evaluated with a model which does not include gait velocity as a 
criterion, is associated with poorer performance on quantitative gait variability 
parameters.  
These findings indicate that measures of gait variability may add valuable 
information beyond that of traditional measures of gait velocity in the assessment of 
frailty. The additional value of gait variability in identifying frailty is grounded in the 
concept that gait variability is an expression of several physiological systems which 
regulate the dynamics of gait (Lipsitz & Goldberger, 1992; Lipsitz, 2004; Montero-
Odasso et al., 2011). High gait variability may therefore be a reflection of diminished 
homeostatic mechanisms and function across these systems. The association between 
increased gait variability and frailty contribute to the concept that frailty is a syndrome in 
which the loss of dynamics across several physiological systems increases vulnerability to 
suffer adverse events (Fried et al., 2001; Lipsitz, 2002; 2004; Montero-Odasso et al., 
2011). This suggests that gait variability may be a potential measure in older adults to 
assess change in function as a result of interventions targeted at improving frailty status.  
Additionally, our study showed that the Clinical Frailty Scale (CFS) can be an 
effective clinical tool for the identification and measurement of frailty in community-
dwelling older adults. The CFS is reliable and comparable to the established Frailty 
Phenotype Index (FPI) in identifying frailty, with the advantage of being easy to 
administer in clinical settings. Improved understanding of the causes of frailty and 
reliable assessment tools to identify frailty in community-dwelling older adult can lead to 
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earlier and more precise identification of older adults to ameliorate risk of frailty related 
outcomes such as falls, mobility decline, disability and mortality. 
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APPENDICES 
  
Appendix A: Frailty Phenotype Index 
FPI components Measure of components 
Slow Gait Velocity  Gait velocity of ≤ 0.99 m/sec  
Low activity  Self-report of sedentary lifestyle 
Low frequency of physical activity (walking, chores, exercising, 
and leisure activities)  
Weakness  Lowest 20% in grip strength (adjusted by gender and BMI)  
Men Cut-off forgrip strength kg) 
BMI ≤ 24 ≤ 29 
BMI 24.1-26 ≤ 30 
BMI 26.1-28 ≤0 
BMI >28 ≤32 
 
Women 
 
Cut-off for grip strength (kg) 
BMI ≤ 23 ≤ 17 
BMI 23.1-26 ≤ 17.3 
BMI 26.1-29 ≤ 18 
BMI >29 ≤ 2 
 
Exhaustion/ Poor 
Endurance  
Positive answer from either of:  
(1) I felt that everything I did was an effort.  
(2) I could not get going.  
OR, answer of “A little/none of the time” to the question, “How 
much of the time during the past 4 weeks did you have a lot of 
energy?”  
Weight loss Self-report of >10lbs lost unintentionally in the last year  
 
Adapted from Fried, L. et al. (2001). 
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Appendix B: Clinical Frailty Scale 
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Appendix C: Frailty & Mobility Study Questionnaire 
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